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Summary 
Objective: Leptin is an adipose-tissue-derived hormone, which regulates 
(suppresses) appetite in animals. No direct physiological role has previously been 
identified in humans, except in the case of rare congenital defects. This thesis tested 
the general hypothesis that another factor - related to physical activity - is necessary 
for normal leptin function. It investigated the effects of moderate exercise on acute 
appetite control and on circulating leptin concentrations in obese and lean women. 
The role of acute physical inactivity on appetite control and on circulating leptin 
concentrations was also investigated by disrupting exercise training for 7 days in 
male athletes. The assessment of the relationship between circulating leptin 
concentrations and appetite/satiety measures and subsequent food intake was used as 
an indirect indicator of the function of leptin. 
Methods: In Study 1 and 2 ten obese (mean age ± SD: 50 ± 8.5 y, mean body mass 
index (BMI) ± SD: 37 ± 6.5 kg-m-2) and ten lean women (mean age ± SD: 37 ± 10 
years, mean body mass index ± SD: 22 ± 2 kg'm-2) were submitted randomly to three 
trials: Moderate physical activity (20 min brisk walking), Snack (58.5 g chocolate-
based) and Control (sitting, TV -watching). 
In Study 3, ten obese women (mean age ± SD: 50 ± 6 y, mean body mass index 
(BMI) ± SD: 36 ± 5.5 kg'm-2, mean waist ± SD: 105 ± 13 em) participated in two 
separate experimental trials: EXP 1 (Moderate exercise plus a/J3 adrenergic blocker 
(labetalol, 100 mg orally) vs Moderate exercise plus placebo (calcium carbonate); 
EXP 2 (Adrenaline infusion for 20 min (12.5 ng min/kg ideal body weight) vs Saline 
infusion trial). In both experiments, trials were double blind and performed in 
random order. In Studies 1, 2, and 3 appetite and satiety were assessed by visual 
analogue scales and serum leptin, blood glucose and plasma free fatty acids were 
measured at baseline, pre- and post-intervention and one h post-intervention (i.e., 
before dinner). A buffet style dinner was provided subsequent to all trials. 
In Study 4, eight endurance-trained athletes (mean age ± SD: 28 ± 12 yrs, mean body 
mass index (BMI) ± SD: 23.6 ± 1.0 kg·m-2) consumed a 1074 kcal (4.5 MJ) meal (67 
% fat, 29 % carbohydrate, 4 % protein) 12 h after overnight fasting, once during 
ii 
training (Trained condition) and once after seven days of detraining (Detrained 
condition). Serum leptin, plasma insulin and glucose, and appetite and satiety ratings 
were measured in the fasting state and at several time points up to 6 h postprandially. 
The results of this thesis depend heavily on assessment of appetite sensations for 
which there is no "gold standard" or objective method. The methods developed by 
Blundell et al were used, employing 10cm visual analogue scales. 
Results: In Study 1 and 2, the moderate physical activity and snack intake both 
produced lower appetite and higher satiety and fullness perceptions, compared to 
control, following the intervention in obese and lean women. No significant 
differences were found in subsequent food intake. Serum leptin concentrations did 
not differ between trials. Serum leptin was not associated with appetite or satiety 
sensations at any time during the control or the snack trials, but was correlated 
following moderate physical activity (prospective food consumption rs = -0.83, P = 
0.003; hunger rs = -0.79, P = 0.007; desire to eat rs = -0.69, P = 0.02; satiety rs = 
0.71, P = 0.02; fullness rs = 0.66, P = 0.04) in obese women. These associations 
were not influenced by BMI or fat mass. No significant associations were found 
between serum leptin and appetite-satiety sensations on any trial in lean women but 
plasma free fatty acid concentrations were significantly associated with appetite and 
satiety ratings only following the snack intake (prospective food consumption r 
0.72, P = 0.03; satiety r = 0.78, P = 0.007; fullness r = 0.71, P = 0.02). 
In EXP 1 of Study 3, blood glucose concentrations were significantly higher (P < 
0.01) and plasma FFA were significantly lower (P = 0.039) following the Moderate 
exercise plus alp blocker compared to placebo. There was no significant difference 
on appetite/satiety measures and on subsequent food intake between the two exercise 
trials. In EXP 2 of Study 3, adrenaline infusion significantly increased energy intake 
(P = 0.04) and carbohydrate intake (P = 0.01) at the subsequent meal. Heart rate was 
significantly increased during the end of the adrenaline infusion compared to saline 
infusion (P :s; 0.01). There was no difference in serum leptin concentrations between 
trials in either EXP 1 or EXP 2 (P> 0.05). 
iii 
In Study 4, compared with training, serum leptin was greater postprandially in the 
Detrained condition (Trained 19.85 ± 6.36 ng·mrl.h, Detrained 26.65 ± 7.85 ng·mr 
I·h (AUe) P = 0.02). Whole-body insulin sensitivity lSI (gly), based on postprandial 
glucose and insulin concentrations, was also higher in the Detrained condition 
(Trained 1.17 ± 0.35; Detrained 0.83 ± 0.18, P = 0.003). Fasting and postprandial 
appetite-satiety ratings did not differ significantly between trials (P> 0.05). Appetite 
and satiety ratings were significantly correlated with serum leptin concentrations 
(Detrained, P < 0.05) 4 hand 6 h postprandially, and with plasma insulin 
concentrations (Trained, P < 0.05) 6 h postprandially, but not at any other time point. 
Conclusions 
Study 1, 2 and 3; Moderate physical activity and snack intake suppress the appetite 
of obese and lean women acutely. The associations between circulating leptin and 
appetite-satiety ratings suggest that there is some physiological involvement of leptin 
in short-term appetite regulation in response to physical activity-induced factors but 
only in obese women. 
The exercise-related factors considered in this thesis as possible mediators of leptin 
action were catecholamines, fatty acids, glucose and insulin. Adrenaline is unlikely 
to be the exercise factor responsible for the coupling between leptin and satiety since 
adrenaline infusion stimulated an increase in subsequent energy intake in obese 
women. Labetalol decreased circulating FF A and increased glucose concentrations, 
which confirms at least p-adrenoceptor blockade. Any conclusions with respect to 
the a- adrenoceptor blockade should be drawn with caution since labetalol, an alp 
blocker, has greater affinity for p- than a-adrenoceptors. No differences in 
appetite/satiety sensations were found following exercise with adrenoceptor blockade 
compared to exercise alone. This indicates that the observed anorexic effect of 
exercise on appetite in obese women was not mediated by p-adrenoceptors. 
Noradrenaline is another possible exercise factor that could mediate the coupling 
between leptin and appetite in obese women since it is known that leptin and 
noradrenaline (NA) have common hypothalamic targets (e.g. NPY) and their effects 
are mediated by a-I adrenoceptors. Labetalol probably was not a sufficiently strong 
a-adrenoceptor blocker to investigate such effects. A study of a more selective al-
iv 
adrenoceptor antagonist might be helpful in the investigation of the interaction 
between leptin and NA in the regulation of eating. 
Study 4: In endurance-trained athletes a short term detraining increases postprandial 
plasma leptin, induces insulin resistance but has no effect on appetite/satiety ratings. 
The results of the present studies implicate leptin, insulin, insulin resistance and 
noradrenergic factors in the control of eating following exercise and detraining. They 
strongly support the promotion of physical activity to help regulate appetite and curb 
excessive food intake. 
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1.1 General Introduction 
Obesity is recognised as a worldwide epidemic, which requires both clinical 
management and public health preventive measures (WHO, 1998), and there is no 
sign that the epidemic is abating over the last two decades. In the majority of 
European countries, where lifestyles and cultures are comparable, the International 
Task Force estimates that the prevalence of obesity increased by between 10 to 40 
per cent from the late 1980s to the late 1990s (Brown, 2000). In England, however, 
the National Audit Office reports that prevalence has almost tripled since 1980 and 
will increase further on present trends (NAO, 2001). In 1980, 8% of women and 6% 
of men were classified as obese in England. By 1998, the prevalence of obesity had 
nearly trebled to 21 % of women and 17% of men. In 2000, NAO predicted that if the 
average rate of increase in the prevalence of obesity between 1980 and 1998 
continued, over one fifth of men and a quarter of women in England will be obese by 
2005, and over a quarter of all adults by 2010. This would bring levels of obesity in 
England up to those experienced now in the United States (NAO, 2001). In fact, by 
2001 over 20% of all adults were already obese. 
Obesity is a disease with International classification of disease code E.66 (World 
Health Organisation, 1997) and is characterised as a disease process of excessive 
accumulation of body fat with multiple organ-specific pathological consequences. 
For epidemiological purposes, adults 'obesity' is now defined by international 
convention to indicate the state of having a BMI > 30 kg/m2, while a BMI of> 25 
kg/m2 is designated 'overweight' and a BMI of < 25 kg/m2 is 'normal' (WHO, 1995). 
These BMI cut offs were initially based on life expectancy data from life assurance 
companies, but they match the overweight-related risks for a range of morbidities. 
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An alternative and more simple measure of overweight and obesity was required for 
health promotion purposes, since the BMI is conceptually complex and inaccessible 
to most of the population (Lean, 2000). Waist circumference is a more recently 
standardised alternative and it relates to total body fatness and specifically to intra-
abdominal fat without the need to adjust for height (Han et aI, 1997). 
Obesity is caused by interplay between genetic constitution and the environment. 
Genetic predisposition clearly contributes to individual differences in body weight 
and fat mass (Barsh et aI, 2000), but the rising prevalence of common obesity is a 
result of the changing environment rather than changes in the biology (Hill et ai, 
2003). There is debate about the key environmental causes of energy 
overconsumption and overweight. Is it the increased food availability and 
consumption of fattening food or the sedentary life style that has triggered the 
obesity epidemic? The changes in food production, distribution and food availability 
in modem societies have indeed created a food environment that promotes weight 
gain. There are significant increases in food availability and fat content in the diet of 
the average American adult (Putnam et aI, 2002). Preliminary data on the nutrient 
content of the U.S. food supply indicated that per capita availability of total dietary 
fat jumped 6% between 1999 and 2000, pushing per capita energy (kcal) availability 
to 3,900 kcal per person per day (USDA'S Center for Nutrition Policy and 
Promotion, 1999). The main food-based candidates for energy over-consumption are 
energy-dense foods (usually high in fat), energy-dense drinks (usually high in sugar) 
and large portion size (Blundell and King, 1996; Prentice, 1998; Rolls, 2000). 
Perhaps even more important have been the major advances in energy-saving 
technologies that promoted sedentary behaviour. Diverging trends of decreasing 
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energy intake and increasing body weight suggest that physical activity may be the 
main determinant of the rising prevalence of obesity (Prentice and J ebb, 1995). There 
is little doubt that machines which reduce the energy cost of occupational work and 
everyday activities, and that provide opportunities for passive recreation have 
increased the levels of physical inactivity (Swinburn and Egger, 2002). Indeed the 
World Health Organisation has reported that total energy expenditure is reduced as a 
result of low physical activity levels in daily living, and declared a fall In 
spontaneous, work-related physical activity as a principal factor that leads to 
overweight (WHO, 1998). 
Television watching has been used in several epidemiological studies as an indicator 
of sedentary lifestyle. On average, western children and adults spent more time in 
sedentary activities, such as watching television than did previous generations (Dietz, 
2001; Jebb and Moore, 1999). Several studies in adults and children, conducted in 
US and in Europe, have reported important associations between the hours of 
television watching and the prevalence of obesity (Martinez-Gonzalez et aI, 1999; 
Dietz and Gortmaker, 1985; Andersen et aI, 1998; Gortmaker et ai, 1996). Although 
physical inactivity is believed to contribute to the rising prevalence of obesity, the 
reasons of appetite and body weight deregulation residing in a physically inactive 
compared to an active environment are unknown. 
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1.2 Exercise and Appetite Regulation 
Appetite regulation involves interactions of many psychobiological systems 
(Blundell et aI, 2001), and appetite is only part of the process that governs food 
consumption. The adipocyte derived hormone leptin is one important part of a 
complex peripheral and central circuit that probably interacts with neurochemical 
mediators of feeding to couple appetite and body weight control in animals and 
humans. The present introduction will discuss current evidence for the role of 
physical activity and inactivity on appetite regulation and how circulating leptin has 
been implicated in appetite regulation in humans. 
A number of studies show that physical activity is associated with the fine regulation 
of appetite and body weight regulation in both mice and humans (Mayer and 
Thomas, 1967). Classic animal studies have demonstrated the importance of exercise 
in prevention or moderation of weight gain (Mayer, 1953; Mayer et aI, 1954). 
Similarly in humans, with observational studies of mill workers suggested that 
appetite may only be 'coupled' with body weight control when moderate physical 
activities are undertaken (Mayer et aI, 1956). More recent studies indicate that 
physical inactivity tends to increase food intake (Murgatroyd et aI, 1999) and 
habitual exercisers control better food intake than sedentary individuals (Long et aI, 
2002). Physical activity is an important adjunct in dietary weight loss programmes 
and necessary in long-term weight loss maintenance. Several qualitative 
retrospective studies found a higher percentage of weight maintainers than non-
maintainers when they engaged in regular exercise (Ewbank et aI, 1995). Prospective 
studies also found improved weight maintenance when exercise was included in 
post-weight loss programmes (Williamson, 1996). How physical activity has this 
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regulatory role for body weight is not clear, but it appears to mediate mechanisms by 
increasing energy expenditure and regulating (suppressing) appetite (Blundell et ai, 
2003). 
The full extent of interactions between exercise and food intake have not been clearly 
established. Intervention studies examining the effect of exercise on food intake are 
difficult to conduct, and have reported conflicting results because of differences in 
experimental protocols, mode of exercise, intensity and duration of exercise, gender 
and age of participants (Blundell and King, 2000). However, the majority of studies 
suggest gender and fat mass as the main indicators of the drive to eat following 
exercIse. 
Intervention studies that investigated the acute effects of exercise on energy intake 
agree that energy intake following exercise in not increasing in obese individuals. 
Kissileff et al (1990) found that energy intake (from strawberry yogurt) following 
moderate and strenuous exercise was lower in obese compared to lean women. In 
another study (Durrant et ai, 1982) it was reported that there were no significant 
differences in acute energy intake following moderate cycling (estimated energy 
expenditure approximately 100 kcal) between obese and lean individuals. Clinical 
studies have also reported that obese women did not increase subsequent energy 
intake following light or moderate exercise (Woo and Pi-Sunyer, 1985; Woo et ai, 
1982a,b). Recently, one study reported higher food intake following moderate 
intensity exercise (1h treadmill walking, 60% maximum heart rate) in obese rather 
than in lean women (George and Morganstein, 2003). In this study food was 
provided in a non-laboratory setting. Participants selected their lunch among a large 
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variety of foods in a familiar cafeteria setting, which might have confounded results 
by stimulating eating (Bellisle, 1999). 
In long-term exercise training studies, evidence suggests that subjects increase 
energy intake to compensate for a high exercise-induced energy expenditure (e.g. 
athletes during training) (Westerterp, 1998; van Baak, 1999; Tremblay et aI, 1985). 
Some studies have reported gender differences in the feeding response to exercise 
training. Lean women tend to increase food intake following exercise training but not 
men (Westerterp et ai, 1992; Tremblay et ai, 1984; Stubbs et aI, 2002a,b). The 
relationship between exercise and subjective appetite or satiety measures is better 
described than food intake, and exercise has been reported to decrease appetite 
sensations in the short-term or not to affect appetite sensations (King et al. 1994; 
King and Blundell, 1995; Thompson et ai, 1988; Hubert et aI, 1998; King et ai, 
1996; Lluch et aI, 2000). It seems that there is agreement among studies that physical 
activity can improve the sensitivity of the appetite control system (Blundell et aI, 
2003). The mechanisms responsible for the exercise-induced appetite suppression 
remain unclear. 
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1.2 Leptin in Appetite Regulation 
The hypothalamus has long been recognised to be the site of the feeding regulatory 
centre, since it was shown that lesions in the medial hypothalamus lead to increased 
food intake and obesity (Bray et ai, 1990). Body weight homeostasis is suggested to 
be maintained via a series of complex interactions between the hypothalamus and the 
periphery, notably via a hormone, leptin, which is synthesised and secreted from 
adipose tissue. In 1994 Zhang et al identified and cloned a gene in the mouse called 
ob gene which was absent in genetically obese ob/ob mice (Zhang et ai, 1994). One 
year later the ob gene was found to encode a plasma protein (Halaas et ai, 1995) 
named "leptin" (Greek leptos adj. (of a person or animal) lean, ancient greek !epo v. t. 
to peel). Leptin was proposed to regulate appetite and food intake by acting in the 
hypothalamus. Administration of leptin either peripherally or centrally reduced food 
intake and body weight in congenitally leptin deficient ob/ob mice, but not in db/db 
obese mice which have a mutation in the leptin receptor (Campfield et ai, 1995; 
Halaas et ai, 1995; Pelleymounter et ai, 1995). The search for obese patients with 
mutations in the ob gene or the ob-r receptor followed (Clement et ai, 1998; 
Montague et ai, 1997; Strobel et ai, 1998). Such mutations are very rare and result in 
morbid obesity in children who are hyperphagic but regain appetite control when 
treated with recombinant leptin therapy (Farooqui et ai, 2002). These findings 
triggered research for leptin as a putative satiety factor in humans, and for a role in 
common obesity (without ob-gene or ob-receptors abnormalities). 
The hormone leptin is known as key regulator of body weight and food intake in 
animals but no simple acute regulatory action has been found in humans (Friedman 
& Halaas, 1998). Studies of recombinant leptin administration showed minimal 
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effects in obese humans. The majority of the obese population has high circulating 
leptin concentrations proportional to increased fat mass (Considine et ai, 1996). This 
indicates that leptin production and secretion is normal but high circulating leptin 
concentrations fail to curtail elevated appetite in obesity. 
Leptin circulates at greater levels in obese than lean individuals, but the ratio of 
cerebrospinal fluid/serum leptin concentrations is greater in lean than in obese 
individuals (Schwartz et ai, 1996). It appeared that the intrinsic sensitivity to leptin is 
variable and that, in general, obese individuals are leptin-resistant (Friedman, 2003). 
Hence, several studies investigated the possibility of defective transport of leptin into 
the brain. The uptake of leptin in the brain was found saturable in vitro and vivo 
animal studies (Banks et ai, 1996; Karonen et ai, 1998), and recently a saturable-
transport mechanism has been also reported in humans (Koistinen et ai, 1998). This 
evidence suggested that leptin uptake into the brain becomes saturated and limited as 
adiposity increases, which may explain why high circulating leptin fails to regulate 
appetite in leptin 'resistant' obese individuals (Caro et ai, 1996). Thus obesity 
pathophysiology may include leptin resistance as an additional 
neuroendocrinological feature. The molecular basis for leptin resistance is not yet 
fully understood but could lead to new treatments. 
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1.4 Proposed model for the function of leptin in the hypothalamus 
Searching for the role of leptin in energy homeostasis there appear to be two 
hypotheses. One is that leptin serves as an antiobesity hormone by acting on the brain 
to inform it about the size of the fat depots. Enlargement of the fat tissue and 
subsequent increases in leptin production and secretion would signal energy 
'affluence' in the brain and lead to decrease in food intake and increase in energy 
expenditure to avoid obesity (Ahima and Flier 2000; Flier, 1998). Alternatively it is 
suggested that absence of leptin is a more important signal at low energy intakes to 
prevent starvation (Jequier, 2002). Leptin has other functions, particularly as a signal 
of the adequacy of energy stores for reproductive function by influencing a number 
of target organs in the hypothalamic - pituitary - gonadal axis. Leptin has also been 
implicated as having a role in hematopoiesis, immune function, angiogenesis and 
osteogenesis (Lee et aI, 2002). 
The physiological actions of leptin are mainly mediated by the interaction with 
neuropeptides, which inhibit food intake and increase energy expenditure. 
Circulating leptin is transported through the blood-brain barrier, possibly via the 
short leptin receptor isoform (ObRa) and reaches the hypothlamus where it binds to 
its long-receptor isoform (ObRb). Following a specific signalling cascade through its 
hypothalamic receptors (Hakansson et aI, 1998), leptin has been proposed to inhibit 
the action of orexigenic peptides e.g. neuropeptide Y, melanin concentrating 
hormone, agouti-related peptide or stimulating anorexigenic peptides e.g. a-
melanocyte stimulating hormone (a-MSH), corticotrophin releasing hormone (CRH), 
pro-opiomelanocortin (POMC), cocaine and amphetamine related transcript (CART) 
(Figure 1.1). By doing so, leptin exerts its effects of decreasing food intake and body 
10 
weight, increasing energy expenditure and fat oxidation, thus favoring leaness 
(Jeanrenaud and Rohner-Jeanrenaud, 2001). 
The anorectic activity of leptin in the hypothalamus is suggested to be partly 
mediated by its inhibition of the noradrenergic system. Studies in rats show that 
leptin inhibits the noradrenaline (NA) release from neuronal endings in the 
hypothalamus (Brunetti et aI, 1999). Noradrenaline release from presynaptic 
terminals in the paravetricular nucleus is known to stimulate food intake (Leibowitz 
and Brown, 1980), probably mediated by u2-adrenoceptors (Wellman et aI, 1993). 
Th~se findings supported that noradrenaline might be also involved in leptin 
signalling in the hypothalamus (Figure 1.1). 
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Figure 1.1: 
Possible model for the regulation of peripheralleptin concentrations and the action of 
leptin in the central nervous system. Serum leptin concentration is mainly influenced 
by body fat content, and by gender. However at any given body weight, there is a 
large range of serum leptin concentrations. The two major biological functions in 
humans eating and exercise/physical activity regulate circulating leptin 
concentrations. Increases in food intake lead to increases in circulating leptin 
concentrations through increases in circulating insulin concentrations in the short-
term and fat stores in the long-term. Increases in exercise/physical activity decrease 
circulating leptin concentrations possibly through catecholamines stimulation in the 
short-term or decreases in fat mass in the long-term. Circulating leptin is transported 
by Ob-Ra receptors through the BBB and into the hypothalamus. Once leptin has 
entered the hypothalamus it binds to hypothalamic receptors Ob-Rb and regulates the 
expression of orexigenic and anorexigenic peptides. In this way appetite and food 
intake are maintained under control. 
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1.5 Leptin response in exercise and feeding studies, and in 
recombinant leptin administration trials 
A plethora of studies have investigated the control of leptin synthesis and secretion 
and the function of leptin in controlling appetite in humans. Firstly, studies that 
investigated whether circulating leptin concentration and/or leptin synthesis is 
acutely affected by energy intake. Secondly, studies that looked at the effects of 
acute exercise and exercise training on circulating leptin concentration and/or leptin 
synthesis, and thirdly clinical trials of exogenous leptin administration have explored 
the use of leptin as an antiobesity drug. 
Physically active and habitually trained individuals also tend to match energy intake 
with long-tenn physical activity (Maughan et aI, 1989), and typically maintain 
constant low body weight throughout life. Physically active and trained individuals 
have lower body fat and circulating leptin concentrations (Leal-Cerro et aI, 1998; 
Considine et aI, 1996) compared to sedentary controls. In contrast, circulating leptin 
is high in sedentary and overweight individuals (Considine et aI, 1996; Fung et aI, 
2000) but this does not prevent overeating and weight gain. These observations 
might indicate that fine coupling between circulating leptin concentrations and 
centrally mediated anorectic and catabolic effects of leptin is obtained only when 
physical activity is undertaken. 
There are many studies that have investigated the physiological regulation of leptin 
in relation to short-tenn and long-tenn exercise training and following single bouts 
of exercise. Because of many confounding factors, such as exercise-induced changes 
in fat mass, the effects of exercise on circulating leptin are not completely clear. 
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Most studies that investigated the effects of acute exercise on leptin have reported 
reductions or no changes in leptin concentrations. Only severe and prolonged 
exercise can decrease plasma leptin concentrations acutely in highly trained men 
(Duclos et ai, 1999; Landt et ai, 1997; Leal-Cerro et ai, 1998; Zaccaria et ai, 2002; 
Koistinen et ai, 1998). A delayed reduction in plasma leptin concentrations has also 
been found at 48 h after high intensity treadmill exercise (~900 kcal during 1 h of 
exercise) or endurance running (Essig et ai, 2000; Oliver and Miller, 2001) or at 9 h 
after heavy resistance exercise in lean men (Nindl et ai, 2002). Thus in trained 
subjects the impact of acute exercise on leptin appears to be delayed until after 
physical activity. 
In sedentary male subjects, moderate intensity exercise for 1 h did not acutely affect 
leptin production and circulating leptin concentrations (Racette et ai, 1997; Zafeiridis 
et ai, 2002). Weltman et al (2000) examined the effects of short duration (30 min) 
treadmill exercise (at intensities below, at and above the lactate threshold) on serum 
leptin and reported no leptin changes irrespective of exercise intensity. Kraemer et 
al (1999) reported a decrease in leptin after 30 min of exercise at 80% V02max in 
postmenopausal women but possible diurnal fall in leptin was considered as 
confounding factor. Fisher et al (2001) investigated serum leptin in response to 41 
min of cycle ergometry at 85% of maximal oxygen consumption and observed no 
effect on young sedentary men. Acute exercise to exhaustion reduced circulating 
leptin concentrations at 120 min after exercise in sedentary men (Elias et ai, 2000). 
These results suggested that acute exercise with greater energy expenditure is more 
influential on circulating leptin concentrations and decreases in plasma leptin 
following single bouts of exercise are manifested 24-48 h post-exercise. 
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There are very few data available on the effects of exercise on 1eptin secretion in 
obese individuals and these come from exercise training studies. Longer-term 
training studies have reported reduced serum 1eptin concentrations induced by fat 
loss (Okazaki et aI, 1999; Perruse et aI, 1997; Thong et aI, 2000; Kohrt et aI, 1996) 
and others have found reductions independent of the fat loss (Hickey et al, 1997; 
Pasman et aI, 1998; Gutin et ai, 1999; Reseland et al, 2001). The decreases in leptin 
concentrations after exercise are suggested to be related, at least in part, to 
sympathetic nervous system activity (Sandoval and Davis, 2003). In animals, this 
exercise effect is mediated by P3-adrenergic receptors (Bramlett et ai, 1999). The 
mechanism in humans remain to be determined but catecholamines are found to 
suppress 1eptin secretion in cultured human adipocytes possibly through activation of 
Pl- and P2-adrenergic receptors (Scriba et aI, 2000). Circulating catecholamine 
concentrations that are elevated by the exercise stress (Shoemaker et aI, 1998) might 
explain the exercise-induced suppression in leptin concentrations. The previous 
studies showed that exercise, possibly through activation of beta-adrenergic 
receptors, inhibits leptin secretion but no studies have investigated the influence of 
exercise on the function of leptin. It is not known (it is hypothesised that) whether 
exercise would influence ( enhance) the transport of leptin into the brain and hence 
activate the effects of 1eptin on appetite regulation in the hypothalamus. 
Several studies have investigated the physiological regulation of leptin and its action 
in relation to feeding interventions. It is suggested that apart from the status of 
energy stores, feeding also influences the expression of leptin by the adipose tissue. 
Serum leptin decreases with fasting for 52 to 72 h, and increases after acute 
overfeeding (12 h) in normal weight and obese individuals (Kolaczynski et aI, 1996; 
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Boden et ai, 1996; Weigle et ai, 1996). Single meals do not appear to affect leptin 
concentrations from 1 h to 4 h postprandially (Clapham et ai, 1997; Considine et ai, 
1996; Dagogo-Jack et ai, 1996; Korbonits et ai, 1997; Ma et ai, 1996; Orban et ai, 
1999) but may transiently increase leptin at 30 min postprandially (Astrup et ai, 
1997) or after 4 h postprandially (Dallongeville et ai, 1998; Romon et ai, 1999). No 
association has been found between leptin and hunger/or desire to eat ratings acutely 
after a meal in lean or obese individuals (Heini et ai, 1998; Karhunen et ai, 1997; 
Romon et ai, 1999). Serum leptin has been associated with appetite ratings only in 
obese individuals after prolonged weight loss (Keirn et ai, 1998; Doucet et ai, 2000). 
These results suggested that adipose-derived leptin regulates energy balance in the 
long-term but does not appear to act as meal-generated satiety signal (Pico et ai, 
2003). 
The regulation of leptin expression by food intake is probably mediated, at least in 
part, by insulin. Accumulating evidence has proposed insulin as a potent regulator of 
plasma leptin concentration. First, a correlation between plasma insulin and leptin 
concentrations has been found in several cross-sectional studies independent of body 
adiposity. Second, insulin stimulates leptin expression in vivo and in vitro (Rentsch 
and Chiesi, 1996; Saladin et ai, 1995). Third, leptin circulating concentrations have 
been found to increase during hyperinsulinaemic-euglycaemic clamp experiments 
(Saad et ai, 1998; Malmstrom et ai, 1996). Insulin sensitivity is also proposed to 
regulate circulating leptin concentrations (Haffner et ai, 1997). Insulin sensitivity is 
associated with reduced plasma leptin concentrations independently of body fat mass 
(Segal et ai, 1996, Guldstrand et ai, 2003) and controls whether high insulin 
concentrations will increase the secretion of leptin (Larsson et ai, 1996). For 
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example, in individuals with insulin resistance high insulin concentrations are not 
associated with increased stimulation of leptin secretion from adipose cells (Saad et 
aI, 1998; Fruehwalt-Schultes et aI, 2002; Tuominen et aI, 1997). 
The clinical trials with leptin replacement therapy in patients with congenital leptin 
deficiency and with recombinant human leptin administration in common obese 
adults have suggested that leptin has biological activity in some obese humans. 
Exogenously administered leptin seems to reduce appetite and food intake at low 
doses and body fat and weight at maximal dose but only in some obese individuals. 
In a young girl with severe obesity (42 kg, 3 yr-old) a mutated ob-gene was found. 
Daily treatment with met-leptin at low doses (0.028 mg/kg lean mass) caused marked 
appetite and food intake reduction, and body weight loss (16.4 kg weigh loss, 95% of 
which was body fat). On treatment this girl weighed 32 kg at the age of 7 years 
(O'Rahilly et aI, 2003). 
Obese individuals (with no abnormalities associated with congenital leptin 
deficiency) have increased serum leptin concentrations and decreased leptin 
sensitivity. Initial trials with recombinant leptin administration aimed to augment 
circulating leptin concentrations to increase leptin signalling and action in common 
obese individuals. A double-blind placebo controlled study examined the safety of 
leptin therapy in 73 obese subjects who self-administered a subcutaneous leptin 
injection daily for either four or 24 weeks (Heymsfield et aI, 1999). A total of 54 
lean individuals were in the control group. Throughout the study, lean subjects were 
maintained on an eucaloric diet, while obese subjects consumed a 500-kcal deficient 
diet. The results of this trial indicated that daily administration of recombinant 
17 
methionyl human leptin induced modest dose-related weight loss in some obese 
subjects with elevated endogenous serum leptin concentrations but not all subjects, 
with a large degree of variability in the amount of weight lost by individual subjects. 
Reductions in fasting hunger ratings and in generalised hunger as measured by the 
three factor eating questionnaire were found after 20 mg subcutaneous treatment with 
recombinant human leptin in obese men (Westerterp-Plantenga et ai, 2001). Despite 
these reductions in the appetite profile, changes in body composition or body weight 
loss compared to placebo treatment were not found. Westerterp-Plantenga et al 
(2000) suggested that recombinant leptin treatment has central rather peripheral 
biological activity in obese individuals. These findings indicate that only a subset of 
obese people respond to leptin therapy with a significant amount of weight loss, but 
the majority appear to be centrally resistant (Caro et ai, 1996) to the action of 
increased plasma leptin concentrations or peripherally administered leptin. 
Therapeutic approaches to deliver leptin effectively into the brain through exogenous 
increases in circulating leptin concentrations are problematic (Mantzoros and Flier, 
2000). Probably the therapeutic approach should target the transport of leptin 
concentrations through the blood brain barrier, which is suggested to be defective in 
obese individuals. 
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1.6 Research Questions that arise from the literature and hypotheses 
to be tested 
For many years the relationship between physical activity-induced energy 
expenditure and energy intake has been the centre of interest through research in 
energy balance (Blundell et aI, 2003). The energy balance is achieved when energy 
intake meets energy expenditure and especially physical activity related energy 
expenditure. Physical activity is recognised as an important component of an obesity 
treatment regimen. Physical activity alone is not particularly effective in producing 
substantial weigh loss, but it is effective in the prevention of weight gain (Rissanen et 
aI, 1991, Hill and Melanson, 1999). Observational, cross-sectional and longitudinal 
studies show that subjects with high levels of physical activity have lower body fat 
and abdominal fat and are less likely to gain total and abdominal fat than those with 
low levels of physical activity (Astrup, 2001; Ross and Janssen, 2001). A number of 
mechanisms linking exercise to successful weight control have been proposed 
(Tremblay et aI, 1999). For example exercise increases energy expenditure. The 
regular physical activity promotes metabolic adaptations, for example, the increase in 
resting metabolic rate and the sympathetic nervous system activity, that facilitate the 
regulation of energy and fat balance. Physical activity may also influence the 
complex regulation of appetite and food intake, including possible effects on insulin 
sensitivity, gastrointestinal hormonal release, behavioural responses and 
neurobiological hormones. 
19 
Summarising, the feeding interventions that were reviewed in this chapter indicated 
that circulating leptin is not importantly involved in acute appetite regulation through 
postprandial metabolic processes. The results of the clinical trials with recombinant 
human leptin administration indicated that leptin has biological activity in at least 
some obese individuals who appear to retain leptin 'sensitivity'. The studies that 
investigated the effects of exercise on leptin concentrations reported that serum leptin 
concentrations decrease following moderate to high-intensity exercise and prolonged 
exercise training. The responses and adaptations of circulating leptin to exercise may 
have important implications because exercise is known to regulate body weight by 
promoting weight loss and maintenance, and by improving appetite control in 
obesity. However the concomitant effects of exercise, if any, on appetite and 
circulating leptin concentrations have not been documented in previous studies. 
It is not clear what causes this feeling of increased satiety or suppressed hunger after 
exercise in some obese and lean individuals. The assessment of possible associations 
between ratings of appetite-satiety and biochemical measures known as hunger or 
satiety signals could provide useful information about the mechanisms of appetite 
regulation. Previous studies have not combined measurements of the drive to eat and 
biochemical measurements, which indirectly assess the sensitivity of the appetite 
control system. Therefore the present studies were designed to investigate the effects 
of exercise on the drive to eat, on subsequent food intake and on serum leptin 
concentrations. Whether there is a relationship between the drive to eat and serum 
leptin concentrations after acute exercise was also investigated as a means of 
assessing leptin sensitivity. 
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2. General Methods 
This chapter describes the general methodologies chosen, developed and used 
throughout this thesis. The thesis comprises of 4 main experimental studies (Studies 
1,2,3 and 4). Methods specific to each study are described in the relevant chapters. 
2.1 Subjects and study approval 
All experiments described in this thesis involved human volunteers recruited by local 
advertisement and word of mouth. The subjects were obese (Study 1 and 3) and 
normal weight (Study 2) women, and well-trained male athletes (Study 4). All 
experiments were approved by the Glasgow Royal Infirmary Research Ethics 
Committee. The nature and purpose of each experiment were explained verbally and 
in writing to each subject prior to each experiment. It was emphasised that subjects 
should only participate in the experiment if they were willing to follow all 
instructions. Subjects were also made aware that they could withdraw from the study 
at any point without being required to provide an explanation. All subjects provided 
written informed consent prior to taking part in an experiment. The results of studies 
1 and 3 in obese subjects were discussed with the subjects to explain the relevance to 
their weight problems. 
2.2 Experimental design and preferred methods (from literature) 
The exercise and dietary interventions described in Studies 1 and 2 followed a Latin-
square block, cross over design. In Study 3 the exercise interventions preceded the 
infusion interventions and all four trials were double blind, placebo-controlled 
randomised trials. In Study 4 the trained condition preceded the detraining 
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intervention. Subjects also acted as their own controls in all experiments. 
2.3 The measurement of the drive to eat and of subsequent food 
consumption 
There is no "gold standard" or objective way to measure appetite or satiety. The 
technique used to evaluate the drive to eat was visual analogue scales (VAS) for self-
report ratings of hunger, desire to eat, prospective food consumption, satiety and 
fullness (Flint et aI, 2000). This is one of the two most common methods for 
assessing feelings of hunger and satiety and has been validated in previous feeding 
studies (Stubbs et aI, 2000). The feelings of desire to eat and prospective food 
consumption are considered as the early phase of the drive to eat. They can be 
triggered by eating-related stimuli (e.g. view of food, smell of food etch.) and can 
motivate eating whilst still being satiated. Feelings of appetite and desire to eat lead 
people to search for food while hunger is considered as the heightened feeling of the 
drive to eat. Hunger is associated with physical symptoms and dominates behaviour 
patterns in quests for food. When hunger is dominant, then actual eating will start. 
The feelings of satiety and fullness follow the food intake and both should signal 
termination of a meal. Fullness is related to gastrointestinal feelings that will stop 
eating and satiety is related to a mental perception of 'fullness' that will signal 'stop 
eating' . 
It is recognised that the terms appetite and hunger may not be interpreted identically 
by different individuals within the general public. There is no definition given for 
these terms in the VAS questionnaires and this might have some influence in 
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reducing the discrimination between these terms. Future questionnaires could 
amplify the distinctions between appetite, desire to eat and hunger and add brief 
definitions/explanations of these terms not included in the present appetite 
questionnaires. 
The visual analogue scales are horizontal lines (often 100 or 150 mm long), 
unbroken and unmarked except for word anchors at either end that describe extremes 
of experience. The subject is instructed to mark the scale with a vertical line at a 
point that most accurately reflects the intensity of the feeling at the moment in time. 
The distance to that mark from the negative end (e.g. not at all hungry) is measured, 
thus having a score of 0-100 millimetres. It is useful that subjects are instructed to 
avoid marking out of either end. Subjects could also be advised that marking exactly 
at the end of the visual analogue scale could represent extreme conditions of hunger 
or satiety i.e., like being hungry of starvation or satiated of overfeeding. In Studies 
1,2, 3 participants were offered a buffet type dinner at the end of each trial. Buffet-
style meals are usually used since they provide a bigger variety of foods than a single 
meal and allow food choice (Hill and Rogers, 1998). Prior to investigation 
participants were asked about food likes and dislikes. In this way, compliance with 
the experimental meal(s) was ensured. The amount of food consumed was measured 
by weighing the food items before and after eating. Each subject's selection from the 
buffet dinner was analysed for energy intake and macronutrient content using a 
computerised version of McCance and Widdowson's food composition tables 
(Holland et ai, 1991). 
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2.4 Blood sampling and analytical procedures 
Arterialised-venous blood samples were obtained at rest in all experiments; this 
method has been validated by Forster et al (1972). This involved heating one hand 
with diagram and placing either a 20 G or 18 G venous cannula in a superficial vein 
on the dorsal surface of the heated hand. In some subjects when sampling from the 
hand proved difficult, a superficial vein in the forearm was used. Subjects were 
comfortably seated with their forarm immersed in water at 42-440 C for at least 10 
min before a resting sample was obtained. The cannula was kept patent by infusing a 
small volume of isotonic saline between samples. Blood was drawn into dry syringes 
and dispensed into tubes containing K3EDT A and into tubes containing coagulation 
factors. Duplicate aliquots (400 Ill) of whole blood from the K3EDTA tube were 
rapidly deproteinised in 800 III of ice-cold 0.3 molT l perchloric acid; following 
centrifugation the supernatant was used for the measurement of glucose (Maughan, 
1982). An aliquot of whole blood was dispensed equally into two eppendorf tubes 
and spun for 3 min and the plasma supernatant was separated and stored at -200 C 
and later used for the measurement of FF A (colorimetric method, Boehringer 
Mannheim Biochemica, London, UK). 
The blood in tubes with coagulation factors was allowed to coagulate and then 
centrifuged; the serum collected was used for the measurement of serum leptin. The 
assay used for leptin analysis was a RIA for total leptin in serum based on a locally 
prepared antibody that is now readily available from Diagnostics Scotland (product 
code no. T270). The minimum detection limit (analyte concentration at an intra-assay 
coefficient of variation (CV) of 22%) was 0.9 ng/ml and the working range (analyte 
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concentration range with intra-assay CV < 10%) was 2.5-50 ng/ml (McConway et aI, 
2000). 
2.5 Statistical Analysis 
Information of data collected was examined by calculating numbers from the data 
(statistics). Data from all experiments are expressed as the mean or median, and the 
measures of dispersion were presented as standard deviation and range. The 
summary extracted from the data were presented in the form of tables and graphs to 
convey information. Statistical analysis of Studies 1 and 2 was carried out using 
Kruskal-Wallis tests followed by Wilcoxon signed rank tests. Statistical analysis of 
Study 3 was carried out using two factor ANOVA for repeated measures followed by 
Student's t-test for paired data where necessary. Statistical analysis of Study 4 was 
carried out using two factor ANOV A for repeated measures followed by Tukey post-
hoc test. T -test for correlated data was used for the additional comparison of 
summary measures of postprandial responses of biochemical and appetite variables 
(time averaged areas under response vs time curves (AVC)). Serum leptin 
concentrations (Study 4) were 10gIO transformed prior to statistical analysis. 
Correlation analysis in Studies 1, 2, 3 was carried out using Spearman's rank 
correlation coefficient (rs) when at least one of the variates did not have normal 
distribution, and Pearson's correlation coefficient (r) (Study 4) when each of the 
variates had a normal distribution. Statistical significance was declared when P :s; 
0.05. 
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Chapter Three 
(Study 1) 
Effects of moderate physical activity or a snack intake on 
hunger/satiety measures, subsequent food intake and serum leptin in 
obese women 
This Chapter presents a study in essentially identical form to its publication in 
International Journal of Obesity 
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3.1 Introduction: Research Questions to be addressed and 
hypotheses to be tested 
Previous studies have used several eating or diet and exercise interventions in an 
attempt to induce changes in circulating leptin concentrations to investigate the link 
between serum leptin and appetite regulation (Astrup et at, 1997; Boden et at, 1996; 
Caixas et at, 2002; Dallongeville et at, 1998; Doucet et at, 2000; Evans et at; 2001, 
Heini et at, 1998; Joannic et at, 1998; Karhunen et at, 1997; Keirn et at, 1998,; 
Kolaczynski et at, 1996; Raben and Astrup, 2000; Romon et at, 1999; Weigle et at, 
1996). Circulating leptin has been considered as a regulator of energy balance during 
prolonged and severe energy deficits (e.g. weight loss, fasting) where, presumably, 
signals increased appetite and food intake for adaptation to food deprivation. Acute 
exercise interventions have involved high-intensity exercise and examined only the 
effects of exercise on leptin synthesis and/or secretion in normal weight or 
overweight men (Duclos et ai, 1999; Landt et at, 1997; Leal-Cerro et at, 1998; 
Perusse et ai, 1997; Racette et ai, 1997). 
The purpose of the present study was to investigate the effects of more moderate 
physical activity and eating interventions, similar to those encountered in normal 
living, on short-term appetite sensations. This was achieved by investigating the 
effect of moderate physical activity in the form of brisk walking and a modest snack 
on appetite sensations and on subsequent food intake in obese women. The 
association between serum leptin concentration and appetite sensations after 
moderate physical activity and snack was also investigated. 
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3.2 Research methods and procedures 
3.2.1 Subjects 
Ten obese but otherwise healthy women (Table 3.1) gave their written informed 
consent to take part in the study, which was approved by the Glasgow Royal 
Infirmary Research Ethics Committee. Of the ten women, five were pre- and five 
were postmenopausal. All subjects were in good physical and mental health, non-
smokers, not on any medication known to affect appetite, not known to be anaemic 
or hyperlipidemic and not on a special diet. 
3.2.2 Experimental design and protocol 
Subjects were first familiarised with the appetite questionnaire (Flint et aI, 2000) and 
kept food and physical activity records for two days preceding the first experimental 
trial and up to arrival at the laboratory. These food and activity patterns were 
replicated before subsequent trials. Household measures (i.e., glasses, cupfuls, 
tablespoons, slices, etc.) were used to quantify food and drink consumption. 
Subjects took part in three experimental trials: Moderate physical activity, Snack and 
Control. The order of the three trials was randomised across subjects in a 
counterbalanced Latin-square design. There was an interval of at least two days 
between trials, and all trials were performed within 2 weeks for each subject. The 
study design is represented diagrammatically in Figure 3.1. On each of the three 
study days, subjects visited the laboratory approximately 2.5 h after having 
consumed a standard lunch. Upon arrival at the laboratory, body mass and height 
were recorded and percentage body fat and fat free mass were measured using a 
Bodystat-1500 Bioimpedance analyser (Bodystat Ltd., Isle of Man) (Kushner et aI, 
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1986). The Bioimpedance analyser uses pairs of electrodes attached to the left hand 
and left foot of the subject. A current of 800 microamps at a frequency of 50 MHz is 
passed between the outer electrodes, and the voltage drop is measured at the 
proximal electrodes, from which the resistance of the tissues is calculated. The 
measured value for impedance is entered into a regression equation, together with 
anthropometric data such as weight, height, age and gender. The bioelectrical 
impedance analysis (BIA) provides a reliable assessment of total body water under 
most conditions in healthy individuals and those with mild-to-moderate obesity. The 
BIA is not reliable in severe obesity (35 kg.m-2 ~ BMI ~ 45 kg.m-2), or as a method 
of estimating the composition of tissues gained or lost during weight change. Despite 
the limitations, studies have found that BIA gives better estimates of body fat than 
those based on skinfolds or weight-height indices (Heitman et aI, 1990). 
Following this, subjects rested in a seated position for 10 min, and a baseline, venous 
blood sample (-60 min) was then taken. The cannula was kept patent by a slow (ca. 
0.5 ml·min- I ) infusion of isotonic saline. Serial blood samples (10 ml) were drawn at 
0, 30 and 90 min. Subjects remained seated and relaxed for at least 10 min prior to 
each blood sample. A set of self-rating 100-mm visual analogue scales for hunger, 
desire to eat, prospective food consumption, satiety and fullness (Flint et aI, 2000) 
was completed after each blood sample. Within-subject comparisons are suggested to 
provide the best use of visual analogue scales, eliminating the inter-subject variation 
in appetite response (Stubbs et aI, 2000). 
Throughout each trial, subjects were seated in a comfortable environment and 
watched food-related videotapes for the first hour. For each trial there was a set of 
30 
videotapes demonstrating recipes of appetizing foods. Food-related videotapes were 
intended to direct participants' attention towards food and eating, to stimulate a 
familiar form of home entertainment which might distract subjects and reduce eating 
restraint (Bellisle and Dalix, 2001). Subjects were required to remain seated for 30 
min (Control trial) or were served a snack (58.5g chocolate-based snack: 1189 kJ 
(284 kcal), 36.0 g carbohydrate, 13.6 g fat, 4.6 g protein) and asked to consume it 
within 20 min while remaining seated (Snack trial) or were asked to walk at a brisk 
pace for 20 min (Moderate physical activity trial). The television was switched off 
for 30 min during each intervention. Following each intervention, subjects continued 
to watch food-related videotapes for another 1 h. Subjects were then served a buffet-
type dinner comprising 10 food items. At dinner, subjects were asked to eat as much 
as they wanted within 1 h. Subjects ate alone and non-supervised during the buffet-
dinner because the number of people present at a meal has been established to 
influence the amount eaten in a meal (de Castro, 2000). All food items were weighed 
before eating, and the leftovers were weighed again at the end of the dinner. Each 
subject's selection from the buffet dinner was analysed for energy intake and 
macronutrient content using a computerised version of McCance and Widdowson's 
food composition tables (Holland et aI, 1991). Water was provided upon request at 
the first trial and subjects were asked to replicate the amount drunk during the 
following two trials. Prior to the study subjects were asked about food likes and 
dislikes to define the snack and the buffet meal, which all subjects would like. 
The brisk walking was performed indoors under supervision in the Clinical 
Investigation Unit of the Department of Human Nutrition. Heart rate was measured 
(Polar Sport Tester, Polar Electro OY, Kempele, Finland) and ratings of perceived 
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exertion (RPE) (Borg, 1982) recorded separately for breathlessness and leg exertion 
at 5 min intervals during the exercise. Subjects were instructed to maintain a level of 
exertion of approximately 13 on the RPE scale (i.e., corresponding to 'somewhat 
hard'). Heart rate at rest and at the end of the moderate physical activity intervention 
was 80 ± 6 and 123 ± 18 bmin-I , respectively (mean ± SD). Subjective perceived 
exertion was somewhat hard (14 ± 2) at the end of the moderate physical activity. 
3.2.3 Blood treatment and analyses 
Venous blood was collected into K 3 EDT A vacutainers for the measurement of blood 
glucose, plasma free fatty acids (FF A) and into clot activator vacutainers for serum 
leptin measurement. Duplicate aliquots (400 f.!l) of whole blood from the K3EDTA 
tube were rapidly deproteinised in 800 f.!l of ice-cold 0.3 mo1'l-l perchloric acid; 
following centrifugation the supernatant was used for the measurement of glucose 
(Maughan, 1982). The remaining plasma supernatant was separated and stored at 
-200 C and later used for the measurement of FF A (colorimetric method, Boehringer 
Mannheim Biochemica, London, UK). Blood collected into the clot activator 
vacutainer was allowed to clot for 10 min. Following centrifugation, the serum was 
stored at -700 C and subsequently analysed for leptin by radioimmunoassay 
(McConway et aI, 2000). 
3.2.4 Statistical Analysis 
Data are expressed as mean ± SD or median (range) as appropriate following a test 
for normality of distribution. Data describing serum leptin concentrations and 
appetite-satiety ratings were not normally distributed, so all comparisons of 
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responses to the three interventions were made using non-parametric tests. The 
Kruskal-Wallis test was performed to determine at which time points there were 
treatment effects. Post-hoc analysis by the Wilcoxon-signed rank test was performed 
to determine treatment difference at each time point and effects over time within 
each treatment. Correlation analysis between serum leptin and appetite measures (for 
each time point separately) and adiposity indices was carried out using the Spearman 
rank correlation coefficient (rs). Statistical significance was taken as P < 0.05. 
3.3 Results 
3.3.1 Effects on self-reported appetite-satiety measures and 
subsequent dietary intake 
Profiles of hunger, desire to eat, prospective food consumption, fullness and satiety 
throughout each trial are shown in Figure 3.2. The Moderate physical activity and 
Snack interventions both induced significantly higher perceptions of satiety and 
fullness compared to Control; ratings were significantly higher compared to Control 
immediately after the Moderate physical activity (P = 0.01 satiety; P = 0.02 fullness) 
and Snack intervention (30 min) (P = 0.01 satiety; P = 0.01 fullness). Only in the 
Moderate physical activity trial was satiety still significantly higher 1 h after the 
intervention (90 min) compared to Control (P = 0.02). Significant suppression of 
hunger was found immediately after the Snack intervention (30 min) compared to 
Control (P = 0.01) and Moderate physical activity (P = 0.03). Desire to eat and 
prospective food consumption were significantly lower immediately after the Snack 
intervention (30 min) compared to Control (P = 0.01 desire to eat; P = 0.01 
prospective food consumption) but only desire to eat was still suppressed 1 h after 
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the Snack intervention (90 min) (P = 0.01). Desire to eat and prospective food 
consumption were also significantly lower immediately after the Moderate physical 
activity intervention (30 min) compared to Control (P = 0.03 desire to eat; P = 0.009 
prospective food consumption). 
Self-selected food intake at dinner did not differ significantly between trials (2860 
(2134-4234 kJ) Moderate physical activity, 2751 (2268-3108 kJ) Snack, 3032 (2134-
5733 kJ) Control; Protein 67.1 (38.4-79.9) g Moderate physical activity, 54.9 (41.3-
70.8) g Snack, 59.7 (35.3-96.2) g Control; Carbohydrate 59.7 (49.8-103.8) g 
Moderate physical activity, 65.3 (34.7-75.6) g Snack, 76.9 (45.0-138.6) g Control; 
Fat 19.6 (6.5-32.7) g Moderate physical activity, 23.9 (13.2-30.3) g Snack, 25.7 
(12.6-51.4) g Control), median (range). 
3.3.2 Effects on biochemical measures 
Serum leptin, blood glucose and plasma FF A concentrations during the three trial 
conditions are shown in Table 3.2. There was no significant effect of any 
intervention or effect over time on serum leptin concentrations (P > 0.05). 
Significant differences between trials were found in blood glucose and plasma FF A 
concentrations after the Moderate physical activity and Snack interventions. Snack 
intake induced significantly higher glucose concentrations immediately after the 
Snack intervention (30 min) compared to Control or Moderate physical activity trial 
(P = 0.009). One h after the Snack intervention (90 min), glucose concentrations 
were still higher in the Snack trial than in the Control (P = 0.02) or Moderate 
physical activity trial (P = 0.02), whereas plasma FF A concentrations were 
significantly lower in the Snack trial compared to the Control and the Moderate 
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physical activity trial (P = 0.009). The Moderate physical activity intervention 
induced higher plasma FFA concentrations immediately after intervention (30 min) 
compared to both the Control and the Snack trial (P = 0.009). Significant time effect 
for glucose and FF A concentrations were found in the Moderate physical activity and 
Snack trials. 
No significant associations were demonstrated between serum leptin and blood 
glucose or plasma FF A concentrations at any time point in the three trials (P> 0.05). 
Baseline serum leptin concentrations correlated significantly with body mass index 
(BMI (kg-m-2) and fat mass (FM (kg) in all trials (BMI rs = 0.73, P = 0.02, FM rs = 
0.88, P = 0.001 Moderate physical activity; BMI rs = 0.69, P = 0.02, FM rs = 0.85, P 
= 0.002 Snack; BMI rs = 0.78, P = 0.008, FM rs = 0.90, P < 0.001 Control). 
3.3.3 Correlations between biochemical measures and self-reported 
appetite-satiety measures 
No significant correlations were found between serum leptin and appetite or satiety 
ratings at any time in the Control or the Snack trial. Only in the Moderate physical 
activity trial was serum leptin concentration significantly correlated with prospective 
food consumption immediately after intervention (30 min) (rs = -0.83, P = 0.003). 
Additionally, 1 h after the moderate physical activity intervention (90 min) serum 
leptin concentrations were significantly correlated with appetite or satiety ratings 
(hunger rs = -0.79, P = 0.007; desire to eat rs = -0.69, P = 0.02; satiety rs = 0.71, P = 
0.02; fullness rs = 0.66, P = 0.04) (Figure 3.3). The associations between leptin and 
appetite-satiety ratings found immediately after and 1 h after the moderate physical 
activity intervention remained significant when circulating leptin concentrations 
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were adjusted for adiposity by dividing by body mass index (30 min hunger rs = -
0.75, P = 0.01; desire to eat rs = -0.75, P = 0.01; prospective food consumption rs = 
-0.86, P = 0.002; 90 min hunger rs = -0.74, P = 0.01; satiety rs = 0.67, P = 0.03; 
fullness rs = 0.66, P = 0.04). The associations also remained significant when serum 
leptin concentrations were adjusted for fat mass (30 min hunger rs = -0.71, P = 0.02; 
desire to eat rs = -0.71, P = 0.02, prospective food consumption rs = -0.84, P = 0.002; 
90 min hunger rs = -0.74, P = 0.01; satiety rs = 0.67, P = 0.03; fullness rs = 0.66, P = 
0.04). 
3.4 Discussion 
The study used brisk walking and a chocolate-based snack, in an attempt to replicate 
typical physical activity and eating behaviours, to investigate the effects on appetite 
and on associations between serum leptin and appetite. Associations between 
circulating leptin and suppressed appetite or elevated satiety were found following 20 
min of moderate physical activity (walking about 1 krn), but not at any time point 
during the snack or the control conditions. 
In other studies of leptin and appetite, circulating leptin concentrations have been 
associated with appetite or fullness perceptions, but only in fasting obese or post-
obese individuals and during weight loss or maintenance produced by diet or diet and 
aerobic exercise (Doucet et ai, 2000; Heini et ai, 1998; Keirn et ai, 1998). These 
observations support the view that leptin regulates appetite centrally only after 
sustained fat loss to re-establish fat homeostasis in fat tissue (Caro et ai, 1996a). In 
contrast, during the process of weight gain, high serum leptin concentrations are 
closely related to body fat (Considine et ai, 1996), but are not usually coupled with 
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appetite suppression in obese individuals. Therefore, serum leptin has not been 
considered to playa role in short-term appetite processes, or there is possibly some 
form of 'resistance' to short-term central actions of leptin in human obesity. 
However, the present study indicates that circulating leptin may indeed be involved 
in short-term appetite regulation in obese individuals but only after physical activity. 
Therefore, physical activity-induced factor(s) may be responsible for the observed 
'coupling' ofleptin to appetite. 
The moderate physical activity employed in the present study, as expected, did not 
affect circulating leptin concentrations. Only extreme exercise (2 to 3.5 h marathon 
running, 2 h of strenuous cycling) is known to decrease plasma leptin concentrations 
(Duclos et ai, 1999; Landt et ai, 1997; Leal-Cerro et ai, 1998). It is likely that 
physical activity could influence leptin transport into the brain which could explain 
the 'coupling' of leptin to appetite found after a bout of moderate-intensity physical 
activity. 
Some studies have suggested impaired leptin transport across the blood brain barrier 
in animals (Banks et ai, 1999) and probably in humans (Caro et ai, 1996b) residing in 
an 'obesigenic' environment (i.e., increased food intake and/or physical inactivity). 
This reduced transport of leptin into the brain is proposed as a possible mechanism 
for leptin 'resistance' in obesity. An exercise effect on leptin transport into the brain 
has not been investigated in humans but animal findings indicate enhanced leptin 
transport into the brain mediated by elevated circulating adrenaline concentrations 
(Banks, 2001). 
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Plasma catecholamines were not measured in the present study. However, increased 
plasma FF A concentrations were found after the moderate physical activity (average 
FF A 1.2 mmon- I), which is indicative of adrenaline-stimulated lipolysis (Cryer, 
1993). Catecholamines have been recognised as important modulators of leptin 
production and secretion (CaruHi et aI, 1999; Couillard et aI, 2002) but whether they 
could regulate leptin uptake into the brain in humans is unknown. If catecholamines 
are responsible for the 'coupling' of circulating leptin to satiety following moderate 
physical activity, then this begins to unravel a mechanism by which physical activity-
induced factors may influence appetite by enhancing leptin transport into the brain. 
The role of exercise as an effective strategy to prevent or attenuate the development 
of leptin resistance is supported by recent findings in rats. Steinberg et al (2004) 
found that endurance training reverses the development of skeletal muscle leptin 
resistance induced by high-fat diet in rats. Leptin has been suggested to have a 
particular function in the hunger drive under starvation conditions (Flier, 1998), but 
may have a more extended physiological role. It is possible that individuals 
predisposed to obesity may need greater physical activity than others, in order for 
serum leptin to be transported into brain efficiently and curtail appetite. 
Circulating catecholamines concentrations are also increased after carbohydrate-rich 
meals in parallel with serum leptin concentrations (Raben and Asrtup, 2000; Raben 
et al. 1994; Raben et aI, 1997), and a positive association has been found between the 
elevated circulating leptin and catecholamines concentrations after a carbohydrate 
rich diet. Food intake, and predominantly carbohydrate intake stimulates leptin 
secretion (Astrup et aI, 1997; Caixas et aI, 2002; Dallongeville et aI, 1998; Doucet et 
aI, 2000; Raben and Astrup 2000; Romon et aI, 1999) but no association has been 
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found between the increased serum leptin concentrations and the heightened 
postprandial satiety in the short-term (up to 9 h postprandially) in lean or post-obese 
individuals (Raben and Astrup 2000; Romon et aI, 1999). 
In the context of weight management for obesity, physical activity or exercise alone 
are better linked with weight maintenance than with enhanced weight reduction 
(Cowbum et aI, 1997; Wing and Hill, 2001). The present results indicated very 
consistently that obese individuals who engage in 20 min of moderate physical 
activity during the course of the day could improve acute appetite control and avoid 
the caloric burden of snacking. The numbers in the current study were small 
increasing the chance of type 2 errors but there was no previous source of bias, 
which might confound these results. Baseline measures of appetite and satiety 
sensations and of biochemical variables were no different between subjects in the 
three trial conditions. This indicates subjects' adherence to instructions to standardise 
diet and physical activity for two days prior to each study day. The consumption of a 
modest snack (1189 kJ) produced lower feelings of appetite and higher satiety-
fullness perceptions, as expected, but did not decrease subsequent food intake. 
Similarly, a short bout of brisk walking equivalent to approximately 502 kJ energy 
cost, increased satiety-fullness perceptions transiently, and most importantly did not 
increase the subsequent food intake. Moderate-intensity physical activities can be 
adopted by obese individuals to promote satiety and are more likely to be continued 
than high-intensity physical activities (Pollock, 1988). 
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The present study assessed appetite and satiety in relation to snacking or moderate 
physical activity in the afternoon and evening. Most previous research has been 
conducted with the morning fasting state as baseline, but it is in the afternoon or 
evening that most obese individuals tend to report higher food intake (Andersson and 
Rossner, 1996). Snack intake did not decrease the subsequent food intake, and serum 
leptin concentrations in accordance with previous studies (Heini et ai, 1998; Joannic 
et ai, 1998; Romon et ai, 1999) were not associated with post-snack satiety ratings. 
Hence, circulating leptin concentrations do not appear to be primary regulators of 
short-term satiety following a meal. The observations that moderate physical activity 
can suppress appetite without increasing subsequent food intake, supports the view 
that the apparent urge to eat, experienced by obese women, may be a misinterpreted 
signal of boredom whilst physically inactive. However, studies in normal weight 
individuals are needed to explore this possibility. The present results suggest that 
moderate physical activity could be used to prolong meal-induced satiety and 
suppress the drive to eat during the early post-prandial phase, i.e., the period of 
'readiness to eat'. 'Readiness to eat' appears to be resumed soon after meal cessation, 
when there is still relative satiation and before appetite has developed. 
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3.5 New Research Questions arising from this study 
These results therefore support a specific role for moderate exercise in linking 
circulating leptin to appetite regulation in obese women. Whether there is a coupling 
between leptin and appetite regulation following moderate exercise in lean women is 
one of the new research questions raised from this study: 
1. What is the effect of moderate exercise or a mild snack on appetite sensations, 
subsequent food intake and serum leptin in lean women? 
2. Is there a coupling between circulating leptin and appetite control following 
exercise or snacking in lean women? 
41 
Table 3.1 Subject characteristics, n = 10 
Age (years) 50± 8 
Weight (kg) 96 ± 18 
Height (cm) 161 ± 5 
BMI (kg'm-2) 37±6 
Fat mass (kg) 45 ± 10 
Fat mass (%) 47±4 
Fat free mass (kg) 50± 9 
Fat free mass (%) 53 ±4 
Values are mean ± SD. 
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Table 3.2 Self-selected nutrient intake of obese women at dinner after the trial conditions 
Control Moderate exercise Snack 
Energy intake (kcal) 724 (509-1369) 683 (509-1011) 657 (541-742) 
(kJ) 2751 (2268-3108) 2860 (2134-4234) 2751 (2268-3108) 
Protein 
(g) 49 ± 17 45 ±16 39 ± 12 
Carbohydrate 
(g) 84±40 75 ± 31 66±24 
Fat 
(g) 22± 12 23 ± 11 23 ± 13 
Values are median (range) 
No significant differences were found between the three trial conditions 
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Figure 3.1: Schematic representation of the study design. 
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Figure 3.2: Median profiles of self-reported appetite-satiety ratings under the Moderate 
physical activity (_), Snack (.) and Control (.) trials; Data were analysed using 
Kruskal-Wallis test followed by Wilcoxon-signed rank test to determine the differences 
in ratings between trials. *, t, t indicate significant differences between trials, P < 0.05 
(*: Moderate physical activity vs Control; t: Snack vs Moderate physical activity; :: 
Snack vs Control); § II ** are significantly different from baseline within the Moderate 
physical activity (§ P < 0.05), the Snack (II P < 0.05) or the Control (** P S 0.01) trial. 
The range has been excluded for clarity reasons. 
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Figure 3.3: Spearman rank associations between ranked serum leptin concentrations 
(ng'mr!) and ranked appetite-satiety measures (recordings on a O-lOO-mm scale) in the 
physical activity trial 1 h after the moderate physical activity intervention (hunger (rs = 
-0.79 P = 0.007); desire to eat (rs = -0.69 P = 0.02); satiety (rs = 0.71 P = 0.02); fullness 
(rs = 0.66 P =0.04). 
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Chapter Four 
(Study 2) 
Effects of moderate exercise or a snack intake on hunger/satiety 
measures, subsequent food intake and serum leptin in lean women 
This Chapter presents results of a study in essentially the same form as has been 
prepared for submission to Appetite 
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4.1 Introduction: Research Questions to be addressed and 
hypotheses to be tested 
In Chapter 3 (Study 1) an inverse relationship between serum leptin concentrations 
and satiety or appetite ratings was found acutely following moderate exercise in 
obese women. These results were the first to report leptin involvement in the 
disordered short-term appetite regulation of obese individuals. The results led to a 
new research question. What is the relationship between leptin and appetite after 
exercise in lean women? Is serum leptin coupled with appetite control, by moderate 
exercise, in lean women too? The present study investigated the influence of 
moderate exercise on the association between serum leptin and appetite in lean 
women. In this way leptin sensitivity after moderate exercise was indirectly assessed 
in lean women. 
4.2 Research methods and procedures 
4.2.1 Subjects 
Ten lean women (Table 4.i) gave their written informed consent to take part in the 
study, which was approved by the Glasgow Royal Infirmary Research Ethics 
Committee. Subjects were recruited by advertisement, which required lean, never-
obese women in good physical and mental health, non-smokers, not on any 
medication known to affect appetite, not known to be anaemic or hyperlipidemic, 
and not on a special diet or exercising regularly (more than 2 times per week). 
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4.2.2 Experimental design and procedures 
The same study design and experimental procedures were used, as previously in 
obese women (Chapter 1, Study 1). Subjects took part in three experimental trials: 
Moderate exercise, Snack and Control. The order of the three trials was randomised 
across subjects in a counterbalanced, Latin-square design. There was an interval of 
at least two days between trials, and all trials were performed within 2 weeks for 
each subject. 
On each of the three study days, subjects visited the laboratory approximately 2.5 hrs 
after having consumed a standard lunch. Upon arrival at the laboratory, body mass, 
waist and height were recorded. Body fat was measured using an air displacement 
plethysmograph, the BOD POD (McCrory et aI, 1995). Plethysmography determines 
body volume based upon the pressure/volume relationship. Boyles' law explains this 
relationship at isothermic conditions. PV = k where k is the proportionality constant. 
The BOD POD is a single 'egg' shaped unit consisting of two chambers; a testing 
chamber where the subject sits and a reference chamber where the breathing circuit, 
pressure transducers, and electronics. The testing procedure involves several steps. 
First, calibration was conducted prior to subject entry into the BOD POD. After the 
calibration was completed and procedures fully explained to the subject the relevant 
clothing scheme and swimcap (worn to minimize isothermal air trapped within the 
hair) were donned. The subject entered the BOD POD for two trials for 
approximately 45 seconds each. During this stage the subject's raw body volume 
(Vbraw) was determined with the testing chamber door being opened between trials. If 
both volumes were within 150 ml then the two trials were averaged. However, if the 
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trials were not within 150 ml a third trial was performed and the two trials that were 
the closest were averaged. 
Throughout each trial, serial blood samples (10 ml) and subjective appetite and 
satiety sensations (Flint et aI, 2000) were measured as previously described (Study 1, 
Chapter 3). In the moderate exercise trial, heart rate (Polar Sport Tester, Polar 
Electro OY, Kempele, Finland) and ratings of perceived exertion (RPE) (Borg, 1982) 
were recorded. Heart rate at rest and at the end of the moderate exercise intervention 
was 76.5 ± 9 and 135.6 ± 12 b'min-I, respectively (mean ± SD). Subjective perceived 
exertion was somewhat hard (13 ± 2) at the end of the moderate exercise. Following 
each trial, subjects were served a buffet-type dinner. Each subject's selection from 
the buffet dinner was analysed for energy intake and macro nutrient content using a 
computerised version of McCance and Widdowson's food composition tables 
(Holland et aI, 1991). 
4.2.3 Blood treatment and analyses 
Venous blood was collected into K 3EDTA vacutainers for the measurement of blood 
glucose, plasma free fatty acids (FFA) and into clot activator vacutainers for serum 
leptin measurement. Duplicate aliquots (400 /-11) of whole blood from the K 3EDTA 
tube were rapidly deproteinised in 800 /-11 of ice-cold 0.3 molT! perchloric acid; 
following centrifugation the supernatant was used for the measurement of glucose 
(Maughan, 1982). The remaining plasma supernatant was separated and stored at -
20° C and later used for the measurement of FF A (colorimetric method, Boehringer 
Mannheim Biochemica, London, UK). Blood collected into the clot activator 
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vacutainer was allowed to clot for 10 min. Following centrifugation, the serum was 
stored at -700 C and subsequently analysed for leptin by radioimmunoassay 
(McConway et aI, 2000). 
4.2.4 Statistical analysis 
Data are expressed as mean ± SD or median (range) as appropriate following a test 
for normality of distribution. Statistical analysis of the data was carried out using 
Kruskal-Wallis Wilcoxon signed rank test. Correlation analysis between serum 
leptin, body composition measurements and appetite perceptions (for each time point 
separately) was carried out using the Spearman rank-order correlation coefficient 
(rs). Statistical significance was taken as P < 0.05. 
4.3 Results 
4.3.1 Effects on appetite and satiety ratings in lean women 
Profiles of hunger, desire to eat, prospective food consumption, fullness and satiety 
throughout each trial are shown in Figure 4.1. Snack intake induced significantly 
higher perceptions of satiety and fullness compared to Control and Moderate exercise 
trials, ratings were significantly higher immediately after the Snack intervention 
(30min) (P = 0.03 satiety; P = 0.01 fullness) compared to Control, and 1 hr after the 
Snack intervention (90 min) compared to Control (P = 0.01 satiety; P = 0.04 
fullness) and Moderate exercise (P = 0.007 satiety; P = 0.02 fullness). Desire to eat 
was significantly lower 1 hr after the snack intervention (at 90min) compared to 
Control (p = 0.03 desire to eat). Moderate exercise similarly induced significantly 
higher fullness perception immediately after the intervention (30 min) (p = 0.03 
fullness) compared to Control. There were no significant differences in hunger or 
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prospective food consumption ratings at any time point between the three trials. Self-
selected energy and macronutrient intake at dinner did not differ significantly 
between trials (Table 4.2). 
4.3.2 Effects on biochemical measures 
There was no significant effect of intervention on serum leptin concentrations and no 
significant time-by-condition interaction (P > 0.05). There were significant 
differences in blood glucose and plasma FF A after the interventions. Snack intake 
induced significantly higher glucose concentrations immediately post-intervention 
(30 min) compared to Control (P = 0.01) or Moderate exercise trial (P = 0.01). One 
hr post-intervention glucose concentrations were still higher in the Snack trial than in 
the Control (P = 0.01) or Moderate exercise trial (P = 0.01), whereas plasma FFA 
concentrations were significantly lower in the Snack trial compared to the Control (P 
= 0.005) and the Moderate exercise trial (P = 0.005). Moderate exercise induced 
higher plasma FFA concentrations compared to the Control (P = 0.005) and the 
Snack trial (P = 0.005) immediately post-intervention (30 min) (Table 4.3). 
No significant correlations were found between serum leptin and blood glucose or 
plasma FF A concentrations at any time point in the three trials (P > 0.05). Baseline 
serum leptin concentrations correlated significantly with body mass index (BMI 
(kg.m-2), fat mass (FM (kg) and percent fat mass (FM (%) in all trials (BMI rs = 0.74, 
P = 0.01; FM rs = 0.84, P = 0.002, FM (%) rs = 0.81, P = 0.005). 
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4.3.3 Correlations between biochemical measures and self-reported 
appetite-satiety ratings in lean women 
Hunger, desire to eat and fullness ratings were significant correlated with blood 
glucose concentrations only pre-intervention in the Moderate exercise trial. Fullness 
correlated positively (rs = 0.75, P = 0.03), and hunger and desire to eat correlated 
negatively with blood glucose concentrations immediately pre-intervention (0 min) 
(hunger rs = -0.76, P = 0.03; desire to eat rs = -0.75, P = 0.03). Significant 
correlations were found between plasma FF A concentrations and hunger-prospective 
food consumption or satiety-fullness sensations 1 hr post-intervention (90 min) only 
in the Snack trial (prospective food consumption rs = -0.72, P = 0.03; satiety rs = 
0.78, P = 0.007; fullness rs = 0.71, P = 0.02) (Figure 4.2). No significant correlations 
were found between serum leptin concentrations and appetite-satiety ratings at any 
time in the three trials in lean women. 
4.4 Discussion 
In chapter 1, it was found that circulating leptin concentrations are coupled with 
"controlled" appetite after moderate exercise in obese women. The present study 
(Study 2) aimed to find out what is the relationship between serum leptin and 
appetite control after moderate exercise in lean women. Therefore exercise in the 
form of brisk walking and snack intake were used in lean women identically to those 
tests in obese women, and the effects on appetite/satiety ratings, subsequent food 
intake and serum leptin were investigated. 
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Similar results of decreased desire to eat after moderate increases in daily physical 
activity (~1 00 kcal/day) have been reported in both obese and lean women (Durrant 
et ai, 1982). A short-lived (15 min) suppression of appetite has been clearly 
demonstrated after acute exercise (cycling 60-77% V02max, 27-120min) in lean men 
(King et ai, 1994; King and Blundell, 1995; Thompson et ai, 1988) but not in women 
(Hubert et ai, 1998; King et ai, 1996; Lluch et ai, 2000). However the present study 
was conducted in non-regularly exercising women who reported increased fullness 
after moderate exercise, whereas regular exercisers (at least 3 times per week) have 
been previously tested (Hubert et ai, 1998; King et ai, 1996; Lluch et ai, 2000). This 
difference in habitual exercise state may explain why exercise did not influence 
subjective appetite in these previous studies. 
Snack intake increased satiety and decreased hunger feelings in lean women, which 
is probably related to elevated postprandial blood glucose concentrations. Mayer 
(1955) postulated that 'short-term articulation between energy needs and energy 
intake was under glucostatic control'. Postprandially, plasma FF A concentrations 
were lower and blood glucose concentrations were higher in lean women. 
Associations between plasma free fatty acid concentrations and hunger suppression 
or elevated satiety were found one hr following the snack intake, but not throughout 
the control or exercise conditions in lean women. This biological profile is indicative 
of suppressed hunger and not eating (Himaya et ai, 1997), possibly through the 
increased postprandial glucose metabolism. After a carbohydrate and fat-containing 
meal, carbohydrate oxidation prevails over fatty acid oxidation and stimulates 
lipogenesis. Thus, ingested fat is less readily oxidised and preferentially stored (Flatt 
et ai, 1985; Jequier, 1994). The transient increase in blood glucose is thought to be 
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the signal of affluent available glucose, which is detected by central glucoreceptive 
elements that induce satiety (Bray, 2000). However it is interesting that plasma FF A 
but not blood glucose concentrations were associated with the increases in 
postprandial satiety/fullness perceptions. The snack intake 1189 kJ (284 kcal) did not 
affect subsequent food intake. These results agree with previous findings. Rolls et al 
(1991) found that neither a high carbohydrate nor a high fat snack (both 1.46 MJ) 
consumed 180 min before a meal reduced subsequent food intake. Porrini et al 
(1997) obtained similar results with a less energetic high protein or high fat snack 
(0.65,0.79 MJ respectively) consumed 160 min before a test meal. Marmonier et al 
(2000) found that a nutritionally balanced snack (1 MJ) consumed in a satiated state 
did not affect subsequent food intake in an ad libitum lunch. No significant 
differences were found in energy intake between the three trial conditions. However 
it should be noted that the sample power could be calculated retrospectively after this 
study has been undertaken in lean women, and non significant differences in average 
energy intake (i.e. 594 kcal Snack, 670 kcal Moderate Exercise, 724 kcal Control) 
might be significant with more subjects. 
No association was found between circulating leptin and hunger or satiety sensations 
following snack intake or moderate exercise in lean women. This would be in 
keeping with previous studies, which have reported no association between 
circulating leptin concentrations and postprandial satiety in lean or obese individuals 
(Joannic et aI, 1998; Heini et aI, 1998). Serum leptin concentrations were not 
associated with higher fullness following exercise in lean women. The present Study 
2 suggests that moderate exercise can induce increased fullness in lean women 
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acutely. This effect of exercise on appetite control is not associated with circulating 
leptin concentrations in lean women. 
4.5 New Research Questions arising from this Study 
The present Study 2 indicates similarities in the behavioural appetite control 
following snacking or moderate exercise between lean and obese women, but 
differences in the biological control of appetite between between lean and obese 
women. Leptin does not appear to be involved in acute appetite control after exercise 
in lean women. It is possible that lean individuals do not need exercise-related 
factors for leptin to function and regulate appetite because they have normal leptin 
secretion and transport (Schwartz et aI, 1996). Alternatively different transport 
pathways of leptin might exist between lean and obese individuals. This study thus 
raises some new research questions: 
1. Is the transport of leptin different between obese and lean individuals; is the blood 
brain barrier the predominant transport site of leptin in obese compared to lean 
individuals? 
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Table 4.1 Subject characteristics, n = 10 
Age (years) 37 ± 10 
Weight (kg) 57 ± 6 
Height (cm) 163 ± 6 
Waist (cm) 73 ± 7 
BMI (kg.m-2) 22±2 
FM(%) 27± 7 
FM (kg) 15 ± 5 
FFM (%) 73 ± 7 
FFM (kg) 42±4 
Values are mean ± SD 
58 
Table 4.2 Self-selected nutrient intake of lean women at dinner after the trial conditions 
Control Moderate exercise Snack 
Energy intake (kcal) 724 ± 286 670 ± 244 594 ± 208 
(kJ) 3031 ± 1197 2805 ± 1021 2487 ± 871 
Protein 
(g) 49± 17 45 ±16 39 ± 12 
Carbohy drate 
(g) 84±40 75 ± 31 66±24 
Fat 
(g) 22± 12 23 ± 11 23 ± 13 
Values are mean ± SD 
No significant differences were found between the three trial conditions 
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Figure 4.1: Profiles of self-reported appetite ratings under the Control (0), Moderate 
exercise (D) and Snack (A) trial. Medians followed by letters a, b, c indicate 
significant differences between trials (a: Snack vs Control, b: Moderate exercise vs 
Control, c: Snack vs Moderate exercise). Medians followed by symbols ., t, # are 
significantly different from baseline within the Control (*), the Moderate-intensity 
activity (t) or the Snack (#) trial, P < 0.05; Ranges have been excluded for clarity 
reasons. 
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Figure 4.2: Associations between plasma FFA concentrations (mmol.rl) and 
fullness-satiety/prospective food consumption measures (on a 0-1 OO-mm scale, 
ranked) 1 hr post-intervention in the snack trial. 
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Chapter Five 
(Study 3) 
Effects of circulating adrenaline concentrations and of moderate 
exercise plus a/f3 adrenergic blockade on serum leptin, 
appetite/satiety measures and food intake in obese women - two 
pilot studies 
This Chapter presents a study in essentially identical form as has been prepared 
for submission to International Journal of Obesity 
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5.1 Introduction: Research Questions to be addressed and 
hypotheses to be tested 
The sympathoadrenal system plays an important role in the regulation of total energy 
balance by affecting both energy intake and energy expenditure (Del Rio, 2000). It is 
functionally separated into the sympathetic nervous system (SNS) and adrenal 
medulla. The SNS is the major regulator of fat mobilisation from adipose tissue to 
provide energy homeostasis in the body (Rayner, 2001). Sympathetic 13-adrenergic 
stimulation is known to evoke an increase in energy expenditure (i.e. thermogenesis) 
under basal fasting conditions (Blaak et ai, 1993). It has also been shown that the 
SNS is responsible for the facultative component of the thermic effect of acute food 
intake in humans (Astrup et ai, 1989). The adrenal medulla, via catecholamines, 
contributes to the regulation of food intake by influencing leptin homeostasis. 
Several human and animal studies indicate that catecholamines stimulate adipose 
signalling to the brain to increase food intake. This is suggested to be mediated 
through 13-adrenergic stimulation, which inhibits leptin mRNA production and leptin 
secretion (Trayhum et ai, 1998, Carruli et ai, 1999). 
Adipose tissue is a heterogenous metabolic organ and several differences in the rate 
of lipolysis have been observed among various fat depots. For example, visceral 
adipose tissue from subjects not selected for age or body weight has a higher 
lipolytic activity than subcutaneous adipose tissue due to a combination of increased 
13-adrenoceptor-mediated catecholamine-induced lipolysis and reduced antilipolytic 
action of insulin in the visceral fat depot. Studies have shown alterations in the 
lipolytic action in various pathological conditions (e.g. obesity and metabolic 
syndrome) but minor regional differences in adipocyte lipolytic response are found in 
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normal weight-healthy conditions (Hoffstedt et ai, 1997). Resistance to 
catecholamine-stimulated lipolysis in subcutaneous adipocytes, due to reduced Ih-
adrenoceptor function, has been found in obese females (Reynisdottir et ai, 1994), in 
subjects with hypertriglyceridemia (Arner et ai, 1993), and in men with the 
metabolic syndrome (Reynisdottir et ai, 1994). Lipolytic subcutaneous 
catecholamine resistance in obese males due to an increased U2 adrenoceptor 
response has also been reported (Mauriege et ai, 1991). In contrast the lipolytic 
function in omental fat cells seems to be enhanced in subjects with upper-body 
obesity and the metabolic syndrome, mainly due to an increased ~3 adrenoceptor 
function (Lonnqvist et ai, 1995, Hoffstedt et ai, 1996). 
In Chapter 3 (Study 1) an association between serum leptin and appetite suppression 
was found in obese individuals, but only following an acute bout of moderate-
intensity exercise. Sedentary and obese individuals have lower exercise capacity and 
elevated cardiac response during moderate exercise compared to normal weight 
controls (Salvadori et ai, 2003). The rapid increase in catecholamines that normally 
accompanies such a response may be responsible for the coupling of leptin and 
appetite. This raises the question whether increased circulating adrenaline 
concentrations could suppress appetite and food intake by enhancing leptin transport 
into the brain. Moreover, adrenoceptor blockade is known to promote weight gain 
(Buemann et ai, 1992). Part of this weight gain mechanism could mimic 
mechanisms that abolish the effect of exercise in promoting satiety by 'uncoupling' 
the effects of circulating leptin. 
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The present chapter 5 includes the results of two experiments that were designed to 
infuse adrenaline (Webber et aI, 1994; Walsh et aI, 1998), to raise circulating 
concentrations to those typically seen during moderate exercise (Gustafson et aI, 
1990) (EXP 1) and on another occasion to administer labetalol, a combined a- and p-
adrenoceptor blocker (Conner, 1983), before moderate exercise (EXP 2). In this way, 
the effects of moderate exercise performed during alp adrenoceptor blockade, and of 
increased circulating adrenaline concentrations by exogenous intravenous 
administration on appetite/satiety measures and on subsequent food intake were 
investigated in obese women. Associations between serum leptin and appetite/satiety 
sensations were also investigated. 
5.2 Research methods and procedures 
5.2.1 Subjects 
Ten obese but otherwise healthy women (Table 5.1) gave their written informed 
consent to take part in the study, which was approved by the Glasgow Royal 
Infirmary Research Ethics Committee. All subjects were in good physical and mental 
health with systolic blood pressure::; 140 and diastolic blood pressure::; 90 mmHg, 
non-smokers, not on any medication known to affect appetite, not known to be 
anaemic or hyperlipidemic and not on a special diet. In EXP 2 (Adrenaline infusion 
vs. Saline infusion) one subject did not fulfil the inclusion criteria thus results are 
from nine subjects. 
66 
5.2.2 Experimental design and procedures 
Subjects kept food and physical activity records for two days preceding the first 
experimental trial and up to arrival at the laboratory. These food and activity patterns 
were replicated before all subsequent trials. Household measures (i.e., glasses, 
cupfuls, tablespoons, slices, etc.) were used to quantify food and fluid consumption. 
Subjects visited the laboratory on four occasions to participate in four separate acute 
interventions; EXP 1: Moderate-intensity exercise plus a- and ~- adrenoceptor 
blocker vs. Moderate-intensity exercise plus placebo, and EXP 2: Adrenaline 
infusion vs. Saline infusion. All trials were double-blinded controlled trials. The 
order of the trials for each experiment (EXP 1 & 2) was randomised separately. 
There was an interval of at least seven days between trials. The study design is 
represented diagrammatically in Figure 5.1. On each experiment, subjects visited 
the laboratory approximately 5 h after having consumed a standard lunch. Upon 
arrival at the laboratory body mass and body composition were measured (Lean et aI, 
1996). Arterialised-venous blood samples (McLoughlin et ai, 1992) was collected 
from a 18 G indwelling catheter placed by percutaneous puncture into a vein on the 
dorsum of a heated hand and a baseline sample (-60 min) was taken. Serial blood 
samples (10 ml) were then drawn at 0, 20 and 80 min. Following each blood sample, 
subjects completed a set of self-rating 100-mm visual analogue scales for hunger, 
desire to eat, prospective food consumption, satiety and fullness. 
Throughout each trial, subjects were seated in a comfortable environment and 
watched food-related videotapes for the first hour. Food-related videotapes were 
intended to direct participants attention towards food and eating, to stimulate a 
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familiar form of home entertainment which might reduce anxiety and eating restraint 
of subjects (Bellisle and Dalix, 2001). After the first hour, subjects took part in one of 
the following interventions on each of the four study days: 
EXP 1 (Moderate-intensity exercise plus a,- and 13- adrenoceptor blocker vs 
Moderate-intensity exercise plus placebo): Prior to each of the two exercise trials, i.e. 
moderate exercise plus alpha- and beta-adrenoceptor blocker and moderate exercise 
plus placebo, subjects were given either 100 mg labetalol (a combined a,- and 13-
blocker) or an equivalent amount of inert 'placebo' (calcium carbonate) 60 min 
before performing exercise. The dosage of 100 mg labetalol ensures that alpha and 
beta-adrenoceptor blockade is obtained (Richards et ai, 1974) without influencing the 
exercise-induced changes in heart rate. Subjects were required to walk on a 
motorised treadmill at a moderate pace for 20 minutes. 
EXP 2 (Adrenaline infusion vs Saline infusion): a single dose of either adrenaline 
hydrochloride (Le., a 1:10,000) diluted in normal saline solution or normal saline, was 
infused intravenously at a rate of 12.5 ng min/kg ideal body weight, via a pump for 
20 min (Webber et ai, 1994), to yield a plasma level not exceeding 1 nmollL. This 
dosage ensures that the plasma adrenaline will not exceed the level typically measured 
following moderate-intensity exercise (Gustafson et ai, 1990). The video was switched 
off for 20 min during each intervention. 
Following each intervention, subjects continued to watch food-related videotapes for 
another 1 h. Subjects were then served a buffet-type dinner comprising 10 food 
items. At dinner, subjects were asked to eat as much as they wanted within 1 h. Each 
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subject's selection from the buffet dinner was analysed for energy intake and 
macronutrient content using a computerised version of McCance and Widdowson's 
food composition tables (Holland et aI, 1991). 
For both experiments, Rating of Perceived Exertion (separately, for breathlessness 
and leg exertion) (Borg, 1982) and Heart rate (Polar Sport Tester, Polar Electro Oy, 
Finland) were recorded every 10 min during the moderate exercise and the infusion 
interventions. For EXP 1, expired gas was collected in Douglas bags for 5 min at 
rest, and thereafter 1 min collections were obtained every 10 min during the 
moderate exercise and the infusion interventions. Expired gases were analysed within 
5 min of collection for [° 2 ] (Servomex 570A, East Sussex, UK) and [coJ 
(Servomex 1400 B4, East Sussex, UK), volume (dry gas meter, Harvard Apparatus 
Ltd., Hertfordshire, UK) and temperature (C6600 10-Channel Microprocessor, 
Comark, Hertfordshire, UK). Barometric pressure was measured using a standard 
mercury barometer. Oxygen uptake (V0 2 ), carbon dioxide production (Vc0 2 ) and 
respiratory exchange ratio (RER) were subsequently determined and, consequently, 
the percentages of fuel oxidation were determined. 
5.2.3 Blood treatment and analyses 
Venous blood was collected into K3EDTA vacutainers for the measurement of blood 
glucose, plasma free fatty acids (FF A) and into clot activator vacutainers for serum 
leptin measurement. Duplicate aliquots (400 Ill) of whole blood from the K 3EDT A 
tube were rapidly deproteinised in 800 III of ice-cold 0.3 molT l perchloric acid; 
following centrifugation the supernatant was used for the measurement of glucose 
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(Maughan, 1982). Plasma supernatant was separated and plasma (500 JlI) was mixed 
with 50 JlI EGTA-glutathione and stored at -700 C for subsequent determination of 
adrenaline and noradrenaline. The remaining plasma was stored at -200 C and later 
used for the measurement of FF A (colorimetric method, Boehringer Mannheim 
Biochemica, London, UK). Blood collected into the clot activator vacutainer was 
allowed to clot for 10 min. Following centrifugation, the serum was stored at _700 C 
and subsequently analysed for leptin by radioimmunoassay. 
5.2.4 Statistical analysis 
Data are expressed as mean ± SD. Statistical analysis of the data was carried out 
using two-way ANOVA for repeated measures followed by paired Student t-test. 
Correlation analysis between serum leptin concentrations and appetite measures (for 
each time point separately) and adiposity indices was carried out using the Pearson 
correlation coefficient (r). Statistical significance was taken as P::; 0.05. 
5.3 Results 
5.3.1 EXP 1: Moderate exercise plus a/~ adrenergic blocker vs 
Moderate exercise plus placebo 
5.3.1.1 Effects on self-reported appetite-satiety measures and subsequent 
dietary intake: Profiles of hunger, desire to eat, prospective food consumption, 
fullness and satiety throughout each trial are shown in Figure 5.2. There were no 
significant differences on appetite/satiety measures between trials, but it is interesting 
that satiety tended to be lower, even if not significant, after the exercise plus blocker 
compared to exercise with placebo. There was an increase in hunger/desire to 
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eat/prospective food consumption measures over time on the Moderate exercise plus 
placebo trial (P < 0.05), and in desire to eat on the Moderate exercise plus blocker 
trial, which stopped transiently immediately after exercise. On the Moderate exercise 
plus blocker trial, no differences were found over time in hunger, prospective food 
consumption or fullness ratings. Self-selected food intake at dinner did not differ 
significantly between trials (990 ± 245 kcal Moderate exercise (a/J3 blocker), 903 ± 
259 kcal Moderate exercise (Placebo); Protein 53.5 ± 14.0 Moderate exercise (a/J3 
blocker), 56.2 ± 17.7 g Moderate exercise (placebo); Carbohydrate 113.0 ± 23.2 g 
Moderate exercise (a/J3 blocker), 106.4 ± 52.5 g Moderate exercise (placebo); Fat 
37.4 ± 14.8 g Moderate exercise (a/J3 blocker), 32.9 ± 10.2 g Moderate exercise 
(placebo), mean ± SD). 
5.3.1.2 Effects on biochemical measures 
Blood glucose, plasma FF A concentrations and serum leptin, during the two trials are 
shown in Table 5.2. There was no significant difference on serum leptin 
concentrations between the two moderate exercise trials but there was an increase 
over time. Serum leptin concentrations were significantly increased immediately 
after moderate exercise (20 min) compared to baseline (-60 min), and not at any 
other time-points, in both trials (P = 0.02 Moderate exercise plus a/J3 blocker, P = 
0.007 Moderate exercise plus placebo). No significant associations were found at any 
time-point between serum leptin and appetite/satiety measures after the moderate 
exercise (P > 0.05). This study therefore failed to replicate the phenomenon 
observed in Chapter 3. 
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Baseline serum leptin concentrations correlated significantly with body mass index 
(BMI (kgm-2), fat mass (FM (kg) and waist (cm) (BMI r = 0.85, P = 0.002, FM r = 
0.63, P = 0.05, Waist r = 0.71, P = 0.02). 
Significant differences were found in blood glucose and plasma FF A between the 
two Moderate exercise trials. Blood glucose concentrations were significantly higher 
and plasma FF A were significantly lower for 1 h after the Moderate exercise plus 
a/p blocker intervention compared to Exercise plus placebo (Table 5.2). 
5.3.2 EXP 2: Adrenaline infusion vs. Saline infusion 
5.3.2.1 Effects on self-reported appetite-satiety measures and 
subsequent dietary intake: 
Profiles of hunger, desire to eat, prospective food consumption, fullness and satiety 
throughout each trial are shown in Figure 5.3. There was no significant difference on 
appetite/satiety measures between adrenaline infusion and saline infusion trials but it 
is interesting that satiety was higher immediately after the adrenaline infusion 
compared to saline infusion. There was a progressive increase in appetite measures 
and a decrease in satiety/fullness over time on both trials which stopped transiently 
immediately after the adrenaline infusion (P < 0.05). 
Self-selected energy intake and carbohydrate intake was significantly greater 
following the adrenaline infusion compared to saline infusion (1146 ± 259 kcal 
adrenaline infusion, 1082 ± 263 kcal saline infusion (P = 0.04); Protein 65.2 ±18.4 g 
adrenaline infusion, 62.6 ± 14.7 g saline infusion; Carbohydrate 128.1 ± 37.2 g 
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adrenaline infusion, 114.6 ± 40.3 g saline infusion (P = 0.01); Fat 44.1 ± 13.5 g 
adrenaline infusion, 43.2 ± 13.4 g saline infusion), mean ± SD) (Figure 5.4). 
5.3.2.2 Effects on biochemical measures 
Blood glucose, plasma FF A and serum leptin concentrations during the two infusion 
trials are shown in Table 5.3. There was no significant difference on serum leptin 
concentrations and blood glucose concentrations between the adrenaline and the 
saline infusions or over time, throughout the trials (P > 0.05). Plasma FF A 
concentrations were significantly higher immediately after the adrenaline infusion 
compared to saline infusion (Table 5.3). 
No significant associations were found between serum leptin concentrations and 
appetite-satiety measures at any time point in the two trials (P> 0.05). Thus again 
this study failed to replicate the phenomenon observed in Chapter 2 .. However, the 
power to detect significant associations could be calculated retrospectively, with the 
data obtained from this study. 
Baseline serum leptin concentrations correlated significantly with body mass index 
(BMI (kg'm-2), fat mass (FM (%) and waist in both trials (BMI r = 0.79, P = 0.01, 
FM r = 0.69, P = 0.04, Waist r = 0.78 P = 0.01). 
5.3.2.3 Cardiopulmonary variables and fuel oxidation rates 
For both experiments, rating of perceived exertion (RPE) (separately, for 
breathlessness and leg exertion) (Borg, 1982) and heart rate (Polar Sport Tester, 
Polar Electro Oy, Finland) were recorded every 10 min during moderate exercise or 
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adrenaline-saline infusion. Heart rate was increased significantly at the end of both 
exercise trials (P < 0.001) in EXP 1 (Table 5.4). In EXP 2, heart rate was 
significantly increased during the adrenaline infusion compared to saline infusion (at 
15 min P = 0.01, at 20 min P < 0.001) (Table 5.5). In EXP 1 oxygen uptake (\10 2 ), 
carbon dioxide production (\1 co 2) and respiratory exchange ratio (RER) were not 
different between trials (Table 5.6). 
5.4 Discussion 
The present study was designed in an attempt to replicate and explain, the coupling 
between leptin and suppressed appetite that was previously (Chapter 3) found after 
exercise in obese women. Evidence in rats suggested that raised adrenaline and 
noradrenaline concentrations might enhance leptin uptake into the brain (Banks, 
2001). We therefore proposed that elevated adrenaline concentrations induced by 
exercise might be responsible for the correlation between serum leptin and 
suppressed appetite that was found after exercise in obese women, and that an a/J) 
adrenoceptor blockade would eliminate this effect of exercise. Considering that our 
sample size is similar to other adrenaline infusion studies (Webber and Macdonald 
1993; Webber et aI, 1994) statistical power is expected to be sufficient to distinguish 
differences between the two study arms in terms of cardio-respiratory and metabolic 
effects. 
Adrenaline was infused intravenously (12.5 ng per kg IBW per minute) to raise 
circulating adrenaline concentrations at levels typically found during moderate-
intensity exercise in obese women (Gustafson et aI, 1990). Heart rate was 
significantly increased towards the end of the adrenaline infusion in the present 
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study, which is in agreement with previous studies (Walsh et aI, 1998). Plasma FFA 
also reached concentrations of 0.95 nrnol·mr1, which is a level known to indicate 
adrenaline-stimulated lipolysis (Webber et aI, 1994). These results indicate that 
plasma adrenaline concentrations were above 0.6 nrnol·mr1 (approximately 0.8 
nrnol·mr1 during 20 min of 12.5 ng per kg IBW per minute infusion), which affects 
heart rate and stimulates lipolysis (Clutter et aI, 1980; Webber et aI, 1994). The 
plasma catecholamine concentrations in the present study will be measured to 
confirm this but assays have been delayed until late 2004. 
In the present study adrenaline infusion for 20 min significantly increased subsequent 
energy intake and carbohydrate intake in obese women. Previous studies of 
adrenaline infusion have found decreased circulating leptin concentrations after 60 
min of infusion (O.OlD J!g/kg fat free mass/min) and speculated that this is associated 
with increased caloric intake (Couillard et aI, 2002). Others have found that 131- and 
132- adrenergic stimulation (adrenaline or insoproterenol infusion) suppresses the 
synthesis ofleptin (ob) rnRNA gene in obese men (Carruli et aI, 1999; Ricci & Fried, 
1999), which then results in decreased circulating leptin levels. 
A possible explanation for the results of the present study is that the adrenaline 
infusion in the present study stimulated beta-adrenergic receptors known to reduce 
the ob-gene expression in adipocytes and this overwhelmed any effect on leptin 
transport and sensitivity. If a decrease in ob-gene expression occurred after the 
present adrenaline infusion and was 'sensed' by central orexigenic mechanisms, then 
this could explain the increased caloric intake following the adrenaline infusion in 
obese women. We did not detect any significant decreases in serum leptin 
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concentrations following the adrenaline infusion, but this may be due to the large 
range of leptin response to adrenaline that is observed in human obesity (Couillard et 
aI, 2002). In our obese subjects, four women (i.e. subjects 4, 7, 8, and 9) appear to 
have reduced leptin concentrations immediately after the infusion and five (i.e. 
subjects 1,2,3,6, 10) did not respond to the adrenaline infusion (Figure 5.5). 
Another possible explanation for the increased energy intake after adrenaline 
infusion could lie in a relationship between raised adrenaline/noradrenaline 
concentrations and hunger-related hormones e.g. increased ghrelin concentrations, 
which stimulate eating (Shiiya et aI, 2002). A positive significant association has 
been found between plasma ghrelin and adrenaline concentrations in chronic heart 
failure patients (Nagaya et aI, 2001), which indicates an interaction between 
circulating ghrelin and catecholamines. 
The study of exercise with the alp adrenergic blockade was a first attempt to 
indentify whether adrenergic stimulation through exercise is involved in appetite 
control. The combined alp blocker labetalol was used in an attempt to abolish the 
effect of exercise on appetite supression and the correlation between leptin and 
appetite in obese women (Study 1, Chapter 3). It was hypothesised that combined 
adrenergic blockade will impair appetite control after exercise compared to placebo. 
Subjects ate a little less (by a mean of 87 kcal) after the moderate exercise with 
placebo (average kcal 903) compared to moderate exercise with alp adrenergic 
blockade (average kcal 990) but this did not reach statistical significance (P = 0.3). 
Labetalol blocks both PI and P2 adrenoceptors, and also al adrenoceptors (Wallin and 
O'Neill, 1983) but with greater degree of P blockade than that of a-blockade (ratio of 
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effective ~/a blockade ~3:1 after oral dosing). Studies in rats and hyperthyroid 
patients have suggested that a-adrenoceptor antagonists, but not ~-antagonists, block 
hypothalamic noradrenergic-induced feeding (Ritter and Epstein, 1975; Pijl et aI, 
2001). Thus the potential effects of catecholamines on hypothalamic food intake 
regulation appear to be mediated by a-adrenoceptors. 
The present results of the blood glucose and plasma FF A concentrations confirm that 
100 mg oral intake of labetalol 1 h before moderate exercise blocked the ~­
adrenoceptor-related lipolytic response to exercise. In the present study labetalol at 
100 mg resulted in lower plasma FF A immediately after moderate exercise compared 
to placebo possibly by blocking the ~-receptor mediated lipolysis in obese women. 
Previous studies have also found reduced arterial plasma concentration of FF A 
during exercise and post-exercise (Hartling et aI, 1980). The a/~ adrenergic blockade 
with labetalol also induced a significant increase in blood glucose concentrations 
after exercise compared to placebo. In other studies, labetalol has been found to 
prevent exercise-induced hypoglycaemia. Christensen et al (1978) reported that 
blood glucose concentration tended to increase after i.v. labetalol in hypertensive 
subjects when standing and during supine exercise. They also observed higher 
plasma noradrenaline concentration after labetalol when standing and during supine 
exercise and higher plasma adrenaline only in the standing position. Hartling et al 
(1980) also found higher arterial blood glucose concentration after labetalol in 
healthy men during dynamic forearm exercise. 
With regard to a- blockade labetalol inhibits the increase in BP induced by 
phenylephrine and noradrenaline while leaving reflex reductions in cardiac output 
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and heart rate unaffected (Richards and Prichard, 1979). In the present study 
labetalol at 100 mg did not produce significant differences in exercise heart rate 
increases 1 h after the oral dosing compared to placebo in our subjects. This is 
probably because labetalol has a-adrenoceptors blockade properties. Similar findings 
have been reported by others. Richards et al (1974) have found that in healthy males 
labetalol at doses of 100, 200 and 400 mg did not significantly alter resting heart rate 
compared to placebo, and significantly reduced exercise-induced increases in heart 
rate only at 2 or 3 hrs after oral dosing. Richards et al (1974, 1977) have shown that 
oral doses of labetalol 100, 200 and 400 mg had no significant effect on peak 
expiratory flow rate at rest or after exercise in healthy males. 
The present findings suggest that elevated adrenaline concentrations by exogenous 
intavenous administration do not mimic the effects of moderate exercise on 
appetite/satiety sensations and subsequent food intake in obese women. In contrast, a 
higher subsequent food intake is found. An alp adrenergic blockade during 
moderate-intensity exercise did not influence appetite/satiety sensations and 
subsequent food intake following exercise in obese women. The changes in blood 
glucose and plasma FF A suggest that the 100 mg of alp adrenergic blocker were 
sufficient to induce p-adrenergic blockade. 
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5.5 New Research Questions arising from this Study 
These results therefore do not support a specific role for adrenaline in linking 
physical activity to appetite regulation via enhanced leptin transport. On the other 
hand, the results do not completely exclude catecholamines as mediators. The 
possibility remains that noradrenaline is the physiologically active compound, and 
studies might more appropriately use pure a- adrenoreceptor blockade to try to block 
its effects. This study thus raises new research questions: 
1. What is the effect of noradrenaline infusion on appetite/satiety ratings and 
subsequent food intake in obese women? 
2. What is the effect of moderate exercise performed with an a-adrenergic 
receptor antagonist on appetite/satiety ratings and food intake in obese 
women? 
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Table 5.1 Subject characteristics, n = 10 
Age (years) 50.3 ± 6.1 
Weight (kg) 90.2 ± 16.5 
Height (cm) 158.0 ± 12.8 
BMI (kg-m-2) 36.1 ± 5.5 
Waist circumference (cm) 104.8 ± 12.8 
Hip circumference (cm) 115.2 ± 9.7 
F at mass (%) predicted by waist 47.7 ± 5.4 
Systolic Blood Pressure (mmHg) 129.6 ± 7.2 
Diastolic Blood Pressure (mmHg) 89.2 ± 4.1 
Values are mean ± SD 
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Figure 5.1: Schematic representation of the study design. 
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Chapter Six 
(Study four) 
Effects of short-term detraining on serum leptin and appetite/satiety 
measures in trained men 
This study presents a study in a form that is essentially the same as a 
manuscript, which has been prepared for submission to International Journal 
of Obesity 
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6.1 Introduction: Research Questions to be addressed and 
hypotheses to be tested 
Combined behavioural and metabolic data have suggested that increased physical 
activity is necessary for accurate control of appetite and body weight. Indeed 
physically active and habitually trained individuals tend to match energy intake with 
energy expenditure (Maughan et ai, 1989), and often maintain constant low body 
weight throughout life. Increases in physical activity are strongly associated with 
lower levels of obesity (Lean, 2000), and regular exercise is positively related with 
long-term weight maintenance after initial weight loss (Fogelholm et ai, 2000). 
Several studies that observed or manipulated physical activity have also suggested 
that inactivity may result in appetite and body weight deregulation (Mayer and 
Thomas, 1967; Murgatroyd et ai, 1999; Long et ai, 2002; Epstein, 2002). These 
observations suggest that long-term adiposity signals, such as serum leptin, finely 
regulate appetite and energy intake during a trained physical state, thus assisting in 
the maintenance of low body weight and adiposity of trained people. 
Trained individuals have increased "leptin sensitivity" i.e. low circulating leptin 
concentrations which seem effective to regulate appetite (Leal Cerro et ai, 1998; 
Considine et ai, 1996) and also increased insulin sensitivity compared to sedentary 
and obese individuals (Mujika and Padilla, 2000). Insulin sensitivity appears to be a 
factor besides obesity that regulates circulating leptin concentrations (Haffner et ai, 
1997). The interrelationship between leptin and insulin sensitivity is demonstrated by 
positive associations between impaired insulin sensitivity and elevated leptin 
concentrations independent of adiposity and fat distribution (Zimmet et ai, 1998). 
The previous Studies 1 (Chapter 3), 2 (Chapter 4) and 3 (Chapter 5) investigated the 
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appetite control and the function of circulating leptin concentrations in relation to 
exercise-related factors in obese and lean women. The findings (Study 1, Chapter 3) 
that exercise-related factors mediated a coupling between serum leptin and controlled 
appetite following moderate-exercise in obese individuals triggered the question 
whether removal of the exercise stimulus would influence appetite control, 
circulating leptin concentrations and the function of circulating leptin concentrations. 
In the present study, the aim was to investigate how short-term detraining (for 7 
days) would influence serum leptin concentrations in endurance-trained men. The 
relationship between leptin, insulin and appetite profile in the trained and the 
detrained condition was examined. Some other aspects of this study are also 
presented elsewhere (Gill et ai, 2003). Insulin data are presented here and discussed 
only in the context of leptin. 
6.2 Research methods and procedures 
6.2.1 Subjects 
Eight endurance-trained men (Table 6.1) gave their written informed consent to 
participate in the study, which was approved by the North Glasgow NHS Trust 
Ethics Committee. Three were distance runners, two were triathletes, two were 
swimmers and one was a cyclist. They had been training regularly for between four 
and ten years and typically performed four to eight hours of endurance training per 
week. Six subjects competed regularly at regional or national level, the other two 
partcipants were recreational athletes. All subjects were healthy non-smokers. None 
were on any special diet or on medication known to affect appetite. 
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6.2.2 Study Design 
All subjects were studied in the fasting state and after consuming a meal 1074 kcal 
(4.5 MJ) on two different occasions, during training (Trained) and after seven days of 
detraining (Detrained). The subjects were asked to undertake their normal training 
routine on the week prior to the first visit (Trained), ensuring that they trained on the 
day before the test, and to keep a training diary during this week. For 7 days before 
the second visit (Detrained), they refrained from training (gentle walking over short 
distances was permitted). Subjects kept weighed food records for two days preceding 
the first test and these food patterns were replicated exactly two days before the 
second test. The subjects were also asked to refrain from alcohol for the two days 
before each test. 
On each of the two study days (Trained or Detrained), subjects visited the laboratory 
at 08:30 h approximately 12 h after their last meal. A venous cannula was then 
inserted and, after an interval of 10 min, a baseline-fasting blood sample was 
obtained. Subjects then consumed a 1074kcal (4.5 MJ) breakfast (fat 67 % of energy, 
carbohydrate 29 % of energy, protein 4 % of energy) within 15 min. Serial blood 
samples were then drawn at 30, 60, 90, 120, 240 and 360 min after the meal 
consumption. Following each blood sample, subjects completed a set of self-rating 
100-mm visual analogue scales for hunger, desire to eat, prospective food 
consumption, satiety and fullness (Flint et ai, 2000). Subjects rested throughout day 
and consumed only water. This was provided ad libitum during the test in the trained 
condition and water intake was replicated in the detrained state. 
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6.2.3 Anthropometry 
Body mass, height and waist were determined using standard techniques (WHO, 
1995). Percentage of body fat (% body fat) was estimated from skin-fold thicknesses 
over the biceps, triceps, sub scapular, and superailiac areas (Durnin and Womersley, 
1974). The skinfolds method is very convenient method in estimating fat in people of 
reasonably normal build, provided that the measurements are made by a trained 
observer and an error of about 3% of body weight (i.e. 2 kg in an average subject) is 
acceptable. Three measurements are made at each site (e.g. biceps, triceps, 
subscapular, and suprailiac), and if the span of readings was greater than 2mm, more 
readings are taken until a set of three consecutive readings agreeing to 2mm is 
obtained. The averages of the three readings at each site are calculated, and the sum 
of these values is entered into the table given by Durnin and Womersley (1974) in 
the column appropriate to the age and sex of the subjects. The percentage of body fat 
related to the sum of the four skinfold values is then estimated. 
6.2.4 Measurements of the metabolic profile and analyses 
Venous blood was collected into EDTA, lithium heparin and into plain serum 
vacutainers for the measurement of plasma non-esterified fatty acids (NEF A) and 
glucose, plasma insulin and serum leptin, respectively, and placed immediately on 
ice. The plasma from the EDT A tube was separated and stored at -700 C. Glucose 
concentration was determined in EDT A plasma by enzymatic colorimetric methods 
using commercially available kits (Roche Diagnostics Gmbh, Mannheim, Germany 
and Wako Chemicals USA, Inc., VA, USA). Insulin was analysed in lithium heparin 
plasma by an in-house immunoradiometric (IRMA) assay using a radiolabelled 
mouse monoclonal anti-insulin and solid phase guinea pig anti-insulin (both 
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antibodies supplied by Scottish Antibody Production Unit) (Dorrian C, PhD thesis). 
Blood collected into the plain serum vacutainer was allowed to clot for 10 min. 
Following centrifugation, the' serum was stored at -700 C and subsequently analysed 
for leptin by radioimmunoassay (Mc Conway et ai, 2000). 
6.2.5 Calculations 
Whole-body insulin sensitivity with regard to insulin effect on glycemia (ISI (gly)) 
was calculated as follows: lSI (gly) = 2/[(INS x GL Y) + 1], where INS and GLY are 
insulin and glucose area under the curve, respectively, over 6 h after meal ingestion 
expressed relative to the average values of the group of subjects (Belfliore et ai, 
2001). 
6.2.6 Statistical Analysis 
Results are shown as mean ± SE unless otherwise stated. Postprandial responses 
were compared by two-way ANOV A for repeated measures followed by the Tukey 
post-hoc test to find the significant differences. T-test for correlated data was used 
for the additional comparison of summary measures of postprandial responses of 
leptin, insulin, glucose and appetite ratings (time averaged areas under response vs 
time curves (AUC)). Whole-body insulin sensitivity was compared by t-test for 
correlated data. Relationships between variables at each time point and between 
AUC were tested with the Pearson's correlations (r). Serum leptin concentrations 
were lOglO transformed prior to statistical analysis. Statistical significance is 
considered as P < 0.05. 
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6.3 Results 
6.3.1 Effects on serum leptin, plasma glucose and insulin 
concentrations 
Data comparing serum leptin concentration are presented in Figure 6.1. Fasting 
serum leptin was not significantly different (ANOVA, P = 0.06) between trials, but 
was greater postprandially in the detrained condition compared with training 
(ANOVA, P = 0.04; Trained 19.85 ± 6.36 ng.mr1·h, Detrained 26.65 ± 7.85 ng·mr 
l·h (AVe) P = 0.02) 
Fasting glucose concentrations were not significantly different between trials 
(Trained, 4.98 ± 0.12 mmo1.rl; Detrained, 5.00 ± 0.08 mmo1.rl) and nor were 
glucose responses to the meal (AVe) (Trained, 31.20 ± 1.99 mmol·r1.h; Detrained 
31.07 ± 1.76 mmol.r1.h). Plasma insulin concentration was higher in the detrained 
trial, both in the fasting state (Trained 4.1 ± 0.04 !lv.mr1; Detrained 5.7 ± 0.6 !lV-mr 
!, ANOVA, P= 0.03) and postprandially (Trained 74.0 ± 6.4 !lv·mr!; Detrained 
102.1 ± 7.7 !lV-mrl (AVe), P = 0.002). Whole-body insulin sensitivity lSI (gly), 
based on postprandial glucose and insulin concentrations, was higher in the 
Detrained condition (Trained 1.17 ± 0.35; Detrained 0.83 ± 0.18, P= 0.003) (Table 
6.2). 
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6.3.2 Effects on appetite and satiety ratings 
Significant changes in hunger, desire to eat and prospective food consumption 
ratings, and in satiety and fullness ratings were found with time during both the 
Trained and the Detrained condition (Figure 6.2). No significant differences were 
found in appetite and satiety ratings at any time-point between the two trials. No 
significant differences were found in the areas under the curve (AVe) of the appetite 
and satiety ratings. 
6.3.3 Correlations between self-reported appetite-satiety measures 
and plasma insulin and serum leptin concentrations in the trained 
and the detrained conditions 
Significant associations were found between plasma insulin and appetite/satiety 
ratings in the Trained condition, and between serum leptin and appetite/satiety 
ratings in the Detrained condition. Plasma insulin concentrations, in the Trained 
condition, were significantly correlated with appetite and satiety ratings 6 h 
postprandially (360 min) (hunger r = -0.73, P = 0.04; desire to eat r = -0.88, P = 
0.004; prospective food consumption r = -0.92, P = 0.001; satiety r = 0.92, P = 
0.011; fullness r = 0.87, P = 0.005) (Figure 6.3). 
In the Detrained condition serum leptin concentrations were significantly correlated 
with appetite and satiety ratings 4 h postprandially (hunger r = -0.79, P = 0.02; 
prospective food consumption r = -0.73, P = 0.04) and 6 h postaprandially (360 min) 
(desire to eat r = -0.91, P = 0.002; prospective food consumption r = -0.82, P = 
0.007; satiety r = 0.75, P = 0.03; fullness r = 0.78, P = 0.02) (Figure 6.4). 
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6.4 Discussion 
Exercise-trained individuals have low circulating leptin concentrations and 
heightened insulin sensitivity. Insulin sensitivity plays a key role in the regulation of 
leptin, however, it was not known how a detraining-induced decline in insulin 
sensitivity would affect serum leptin concentrations in trained individuals. In the 
present study, short-term detraining increased serum leptin concentrations throughout 
the 6 h postprandial study period in endurance-trained men without detectable 
changes in fat mass. Previous studies have not found significant fat mass changes 
after even much longer (3 weeks) detraining (LaForgia et ai, 1999). In our subjects 
the increase in leptin is probably related to detraining-induced factors other than 
changes in fat mass. Gutin et al (1999) investigated the effects of long-term (4 
months) physical detraining in obese children and also found increased serum leptin 
concentrations (adjusted for the increase in fat mass). Leptin concentrations can 
indeed vary disproportionately to changes in fat mass. For example, circulating leptin 
concentrations decrease during prolonged fasting (52 h) and increase during 
overfeeding (12 h) without marked changes in fat mass (Boden et ai, 1996; Weigle et 
ai, 1996). Exercise training also decreases serum leptin concentrations independently 
of fat mass in obese men and children (Pasman et ai, 1998; Gutin et ai, 1999). These 
observations and our findings suggest that leptin is not only a marker of adiposity but 
also indicates the net flux of energy, probably the glucose flux, through adipocytes 
(Considine et ai, 2000). 
Among other biological candidates glucose, insulin and catecholamines are proposed 
as determinants of leptin production and secretion (Dagogo-Jack, 2001). In the 
present study, the fasting and postprandial plasma insulin concentrations were 
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increased but glucose did not change after short-term detraining. Insulin sensitivity 
was impaired by short-term detraining in endurance-trained men, which is in 
accordance with findings of previous studies (five to six detraining days) (Mikines et 
ai, 1989; Vukovich et ai, 1996). Previous studies have shown that high insulin 
concentrations stimulate leptin secretion (Saad et ai, 1998). The increased insulin 
concentrations found after detraining could explain the present increase in leptin in 
our men. Fruehwald-Schultes et al (2002), however, found that experimentally 
induced insulin resistance reduces the stimulatory effect of insulin on leptin secretion 
in lean individuals. Our results indicate that in the case of a 'naturally' induced 
insulin resistance, e.g. detraining-induced insulin resistance, the effect of insulin on 
leptin secretion is not counteracted by insulin resistance in trained men. 
Recent studies have found that glucose uptake and metabolism is suggested to be the 
primary regulator of leptin secretion by human adipocytes rather than insulin per se 
(Wellhoener et ai, 2000). It is known that during training circulating glucose is 
mainly taken up by the skeletal muscle (Malkova et ai, 2000). If during detraining 
adipose tissue becomes the predominant site of glucose disposal and metabolism, this 
may have led to an increase in serum leptin concentrations in these trained men. This 
effect of glucose on leptin secretion is suggested to be mediated through the 
hexosamine biosynthesis in adipose tissue (Considine et ai, 2000). This speculation 
is also supported by our detraining-induced insulin resistance, which is another 
metabolic outcome of the hexosamine biosynthetic pathway (McClain and Crook, 
1996). 
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In the present study, fasting and 6 h postprandial appetite-satiety ratings were not 
influenced after seven days of detraining. The present results, however, suggest an 
association between serum leptin and the late postprandial drive to eat (i.e. 6 h 
postprandially) in detrained men, wherein minimal postprandial satiety is reached 
and maximal hunger is developed. Serum leptin concentrations have been previously 
associated only with fasting appetite ratings in obese individuals possibly due to 
weight loss (Keirn et ai, 1998; Heini et ai, 1998; Doucet et ai, 2000). There is no 
previous evidence of an association between postprandial leptin and early 
postprandial satiety or hunger (i.e. 4 to 9h postprandially) (Joannic et ai, 1998; 
Karhunen et ai, 1997; Romon et ai, 1999). It has been suggested that the association 
between circulating leptin concentrations and hunger and satiety may develop in the 
later postprandial state (Romon et ai, 1999). It seems possible that the detraining-
induced increase in serum leptin concentrations stimulated the present coupling 
between serum leptin and postprandial appetite/satiety sensations in these trained 
men. 
In the trained condition plasma insulin was associated with appetite ratings. This is 
in agreement with previous studies that reported an anorexic effect of insulin in the 
immediate postprandial period (Heini et ai, 1998; Raben et ai, 1994). The shift in the 
association between trained and detrained conditions could be possibly stimulated by 
detraining-induced factor(s). It has been found that improved insulin sensitivity in 
parallel with decreased circulating leptin levels are related to decreased appetite in 
obese rats (Wang et ai, 2001). It is unknown whether this implies the same condition 
in man and if a reversed condition of increased leptin concentrations and/or 
decreased insulin sensitivity would affect appetite regulation in trained men. 
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6.5 New Research Questions arising from this Study 
These results suggest that physical inactivity, for example detraining, increases the 
secretion of leptin in the short-term. This increase is accompanied by impaired 
insulin sensitivity, which probably suggests common exercise-related pathways in 
the regulation of leptin and insulin secretion. Interestingly in the trained state plasma 
insulin was associated with appetite/satiety ratings during an acute postprandial 
profile, but serum leptin overtook this role in the detrained state. The questions 
remain about the effects of long-term physical inactivity on the biological and 
behavioural control of appetite and food intake. This study therefore raises the 
following new research question: 
1. What is the effect of long-term detraining on serum leptin concentrations, insulin 
sensitivity and energy balance in trained and sedentary individuals? 
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Table 6.1 Subject characteristics, n = 8 
Age (years) 28 ± 12 
Weight (kg) 73.7± 17 
Height (cm) 176 ± 0.06 
Waist (cm) 79.3 ± 4.1 
BMI (kg-m-2) 23.6 ± 1.0 
Sum of skinfolds (mm) 39.6 ± 9.4 
Fat mass (%) 17.0 ± 3.3 
Values are mean ± SD. 
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Figure 6.1: Profiles of serum leptin concentrations under the Trained (D) and the 
Detrained (_) conditions; * indicate significant differences between trials (* P < 
0.05). Values are mean ± SEM, n = 8. 
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7.1 Discussion 
At the onset of this work, leptin was already well established to have a critical role in 
appetite regulation in animal models of obesity and in humans with congenitalleptin 
deficiency but its role amongst common obese humans was not clear. The increased 
concentrations of circulating leptin in overweight/obese subjects suggested a 
resistance to the physiological effects of the hormone. Elevated circulating leptin 
concentrations are independent risk factors for coronary heart disease compared to 
BMI and are usually accompanied by a concomitant increase in circulating insulin 
and lipid concentrations (Wallace et aI, 2001). Subjects with the metabolic syndrome 
have also raised serum leptin concentrations despite the increased central body fat 
(waist-hip ratio> 0.90 in men, waist-hip ratio> 0.85 in women) (Bonora et aI, 2003). 
High circulating leptin concentrations thus appear to indicate not only leptin 
resistance but also increased risk for obesity-associated metabolic abnormalities. The 
leptin resistance in overweight and obese individuals possibly limits the therapeutic 
use of leptin in the treatment or prevention of obesity and associated diseases. New 
approaches are therefore needed to overcome the leptin resistance and elucidate the 
use ofleptin in the battle against obesity. 
Physical inactivity triggers or aggravates the onset of several pathologies related to 
sedentary life-style, e.g. obesity, diabetes, heart disease and metabolic syndrome, but 
physical activity prevents many of these diseases. It is important to understand how 
physical activity and inactivity influence appetite and body weight regulation and 
whether circulating leptin is involved in the related mechanisms. Therefore, the 
primary objectives of the Studies 1, 2 and 3 were to determine the effects of 
moderate exercise on acute appetite control and on circulating leptin concentrations 
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in obese and lean women. Study 4 aimed to investigate the role of acute physical 
inactivity on appetite control and on circulating leptin concentrations by disrupting 
exercise training for 7 days in male athletes. The assessment of the relationship 
between circulating leptin concentrations and appetite/satiety measures and 
subsequent food intake was used as an indirect indicator of the function of leptin. If 
circulating leptin concentrations are found to associate with appetite control then this 
might indicate improved leptin sensitivity and effective function of leptin in 
controlling appetite. 
The acute effects of moderate exercise and eating interventions on the drive to eat 
and subsequent food intake were investigated in obese (Study 1, Chapter 3) and lean 
women (Study 2, Chapter 4). The effects on some biochemical measures known to be 
involved in appetite control, e.g. blood glucose, plasma FF A and serum leptin 
concentrations were also investigated. The results in obese women in Study 1 
(Chapter 3), showed correlations between serum leptin concentrations and 
appetite/satiety sensations following moderate-exercise, which raised the possibility 
of an acute 'coupling' between circulating leptin and appetite, mediated by exercise-
induced factors. One plausible explanation is that catecholamines released during 
exercise may be responsible for inducing this 'coupling' between circulating leptin 
and appetite suppression since it is known that they facilitate leptin transport into the 
brain. The increase in plasma FF A concentrations following exercise in obese 
women indicated catecholamine-stimulated lipolysis. Animal findings indeed 
indicate that raised adrenaline concentrations enhance leptin transport across the 
blood brain barrier (Banks et ai, 2001). Once in the brain, increased leptin 
concentrations may alter the balance between orexigenic and anorexigenic 
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neuropeptides in favour of decreased appetite. The role of catecholamines in this 
process therefore merits further investigation. 
In Study 2 (Chapter 4) associations between serum leptin concentrations and appetite 
control were not found in lean women so a primary role could not be demonstrated 
for leptin in the short-term appetite control in lean women. The present results 
suggest differences in the relationship between appetite regulation and exercise in 
obese and lean individuals. Signals other than circulating leptin may mediate 
exercise-induced satiety in lean individuals. Alternatively exercise-induced factors 
necessary to facilitate leptin transport into the brain in obese individuals (Banks et ai, 
2001) may differ or not be needed in lean individuals, i.e. the threshold for coupling 
leptin to appetite is different between obese and lean individuals. 
It is suggested that leptin transport into the brain differs between normal 
weight/healthy and obese/pathological conditions. Absence of sensitive transport 
mechanism for leptin at the blood brain barrier has been observed in normal weight 
rats (Zlokovic et ai, 2000). Alternatively, it has been suggested that the choroid 
plexus was suggested to regulate leptin entry into the cerebrospinal fluid in normal 
weight conditions. Whether the non-coupling between serum leptin and satiety after 
exercise in lean women indicates different regulation of leptin transport in lean and 
obese individuals is uncertain. If leptin transport is lower across the blood brain 
barrier than through the choroid plexus in normal serum leptin concentrations (e.g. 
normal weight individuals), this could explain the non-coupling of leptin to satiety in 
lean women as adrenaline-induced effects on leptin transport have been found at the 
blood brain barrier but not at the choroid plexus (Banks et ai, 2001). Alternatively, it 
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is possible that factors, which promote brain leptin transport and central action, are 
only necessary in obese individuals to curtail appetite. It is known that leptin 
transport into the brain is efficient in lean individuals (Caro et ai, 1996). The low 
concentrations of circulating insulin and leptin appear to inhibit efficiently 
hypothalamic NPY expression in lean but not in obese rats (Schwartz et ai, 1991). 
Hence, it is likely that a transport-enhancing effect of adrenaline/noradrenaline on 
leptin is only required when serum leptin concentrations are high, i.e. in obesity. 
In the Studies 1 and 2 in obese and lean women respectively, the exercise-induced 
satiety resembled the satiety of a snack but most importantly avoided the extra 
calories of snacking. Overall the present observations reported in lean and in obese 
women suggest moderate exercise as an efficient route to appetite and body weight 
control in individuals who wish to avoid weight gain or to maintain weight loss after 
slimming. Moderate exercise is indeed recommended as a snack 'substitute' in 
dietetic practices for weight management. Obese individuals on dietary weight loss 
programmes commonly find it difficult to control their hunger and frequently resort 
to snacking. This is when moderate exercise could be used effectively to induce 
satiety. 
The age and body fat differences between the two subject groups (middle-aged obese 
compared to younger lean women) may be factors that contribute to the difference in 
leptin response to exercise between obese and lean women. The women in the Study 
2 (Chapter 4) were lean and young compared to middle-aged and obese women in 
Study 1 (Chapter 3). It is known that adiposity increases with age (Schwartz et ai, 
1990) and that circulating leptin concentrations dissociate with body fat in older 
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humans (Moller et ai, 1998). Moreover, findings in rats suggested that the inhibitory 
function of leptin on food intake is decreased with age through suppression of 
hypothalamic NPY (Scarpace et ai, 2002). It is also suggested that human obesity is 
associated with leptin resistance, which becomes more pronounced with progressive 
degrees of obesity and aging (Considine et ai, 1996; Scarpace et ai, 2002). For 
example, diet induced obese (DIO) rats are a good surrogate for human obesity and 
develop defective leptin transport only as they age and became obese (Levin et ai, 
2004). It is likely that the exercise-induced factors that appear to mediate the 
function of leptin in suppressing appetite are effective only in obese and middle-aged 
individuals who are prone to leptin resistance. 
Study 3 (Chapter 5) was designed to elucidate whether circulating adrenaline at 
concentrations seen during moderate exercise (Gustafson et aI, 1990) is responsible 
for the exercise-induced coupling of leptin to appetite/satiety found in obese women 
(Study 1, Chapter 3). Adrenaline concentrations raised by exogenous intravenous 
administration (12.5 ng min/kg ideal body weight) to concentrations seen during 
moderate exercise, do not appear to mimic the effects of moderate exercise on 
appetite suppression in obese women. On the contrary, the adrenaline infusion 
increased subsequent energy intake. Adrenaline infusion lasted 20 min to mimic a 
bout of light exercise and was administered 1 hr before the meal. Adrenaline infusion 
may have increased energy intake by inhibiting leptin gene expression (Carulli et aI, 
1999), although no decrease in circulating leptin concentrations was detected. 
114 
In contrast to the above, administration of labetalol, a combined a/~ adrenergic 
blocker before moderate exercise (Study 3, Chapter 5) aimed to abolish any effects 
of the catecholamines in mediating the 'coupling' between serum leptin and appetite 
in obese women (Study 1, Chapter 3). Labetalol was chosen as a safe and well 
understood a/~ blocker, however, it has greater affinity for ~- than a-adrenoceptors. 
For this reason, any conclusions with respect to the a- adrenoceptor blockade should 
be drawn with caution. Labetalol decreased circulating FF A and increased glucose 
concentrations, which indicate inhibition of catecholamine-stimulated lipolysis and 
confirm the primarily ~-adrenoceptor blockade. There is no simple way to know if a-
blockade was completed. No differences in appetite/satiety sensations were found 
following exercise with adrenoceptor blockade compared to exercise alone. This 
indicates that the observed anorexic effect of exercise on appetite in obese women 
was not mediated by ~- adrenoceptors. Indeed, a number of studies attribute the 
anorexigenic effect to a-adrenoceptors in the brain (Ritter and Epstein, 1975; Pijl et 
aI, 2001). It is this effect that a popular class of antiobesity drugs exploit to reduce 
eating behaviour (e.g. sibutramine) by blocking noradrenaline (NA) reuptake through 
activation of brain a l-adrenoceptor receptors (Lean, 2001). 
In Study 4, seven consecutive days of detraining decreased insulin sensitivity and 
increased circulating leptin concentrations in endurance-trained men. There is 
evidence that circulating leptin is regulated by exercise factors but the exact 
mechanism(s) have not been fully understood. A 'nutrient sensing pathway' (the 
hexosamine biosynthetic pathway), which regulates leptin gene expression, has been 
proposed as a possible mechanism by which an exercise-induced energy deficit may 
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decrease serum leptin concentrations (Hulver and Houmard, 2003). Similarly, the 
detraining-induced increases in leptin concentrations may be due to alterations in 
nutrient availability or nutrient flux at the level of the adipocytes. Catecholamines, 
beta-agonists, and agents that increase cellular levels of cAMP all acutely reduce 
leptin mRNA (Trayhurn et ai, 1995). Recent findings suggested that fatty acids 
might mediate the inhibitory effects of catecholamines, e.g. NA on insulin-stimulated 
leptin secretion. In vivo studies using isolated white adipocytes and human 
preadipocytes have shown the intracellular increase in fatty acids, generated by 
activated lipolysis, to result in an inhibition of insulin-stimulated leptin secretion 
(Cammisotto et ai, 2003, Arai et ai, 2002, Van Harmelen et ai, 2002). An elevated 
circulating catecholamine concentration, typical of the trained state, suppresses 
circulating leptin concentrations (Fritsche et ai, 1998; Couillard et ai, 2002). 
Activation of lipolysis in this manner could initiate a signalling cascade that 
suppresses leptin mRNA. Therefore, factors related to CNS alterations could be 
responsible for the increase in leptin concentrations. It is interesting to note that 
detraining results in a decrease in catecholamine release (Shoemaker et ai, 1998) and 
this may have resulted in the increase in serum leptin concentrations observed in 
trained men. Alternatively, the increase in serum leptin concentrations, without 
weight gain in trained men, implies an induction of leptin resistance. This could be a 
result of reduced transport into the brain. 
The association between circulating leptin and insulin concentrations with 
postprandial appetite/satiety was investigated to obtain information about the role of 
these hormones on the short-term drive to eat in trained individuals. Interestingly, 
leptin was 'coupled' with hunger in the detrained condition while insulin was 
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coupled with raised hunger and decreased satiety in the trained condition. These 
associations demonstrated in the present study may suggest different regulators of 
short-term postprandial appetite and satiety during training (e.g. insulin) and after 
detraining (e.g. leptin). Serum leptin concentrations appear to playa role in the 
postprandial appetite/satiety when the action of insulin has been reduced, for 
example after detraining in trained men. Circulating leptin concentrations have not 
been associated with postprandial drive to eat in previous studies, nevertheless the 
present coupling supports a biological function of leptin in appetite regulation in 
detrained conditions. It is possible that in lean trained individuals there is a threshold 
of detraining above which leptin and insulin exchange roles in appetite regulation. 
This is when leptin increases and insulin resistance develops. Further studies are 
required to investigate how the inactivity-induced increase in serum leptin 
concentrations may respond to longer detraining and how it may relate to possible 
concomitant changes in adipose tissue and energy intake in trained and non-trained 
individuals. 
7.2 Conclusions from the present thesis 
The present series of studies aimed to elucidate the role of leptin in acute appetite 
regulation, partiCUlarly in relation to physical activity and inactivity factors. The 
general conclusions and new research questions below are generated from this thesis. 
7.2.1 Conclusions from Study 1 and 2 
The effects of moderate exercise on the drive to eat and subsequent food intake were 
investigated and compared to snacking and sitting (control) interventions. 
Consumption of a chocolate-based snack suppressed appetite transiently but did not 
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decrease subsequent food intake in both obese and lean women. Moderate exercise in 
the form of brisk walking induced higher satiety and fullness sensations acutely in 
obese and lean women. These results support the use of moderate exercise for people 
that often fail in controlling appetite, for example overweight and obese individuals. 
The associations between leptin and suppressed appetite/elevated satiety support a 
biological role for leptin in appetite regulation, but only in obese women, which is 
probably mediated through moderate exercise. These observations extend our 
understanding for the role of moderate physical activity in appetite regulation and 
obesity prevention. Physical activity may have a permissive role, allowing effective 
signalling from a high leptin concentration to curtail appetite. This could explain, 
firstly the paradoxical finding of deregulation of appetite during chronic inactivity 
(Mayer and Thomas, 1967). Secondly, it provides a mechanism for why inactivity 
(Le., watching television, often in the afternoon and/or evening) is having such 
pervasive effects on appetite and body weight regulation (Dietz, 2001), possibly by 
an 'uncoupling' of circulating leptin to appetite control. Additionally, the present 
findings may offer an explanation for the disappointing results in clinical trials with 
recombinant human leptin administration, which alone, provides little benefit in 
obesity treatment (Hukshorn et aI, 2000). Physical activity trials in conjunction with 
recombinant leptin administration might be a new approach to investigate the 
potential therapeutic role of leptin in obesity and related diseases. 
The exercise-induce appetite suppression has been documented in animal and human 
studies but the related-mechanisms remain unclear. Studies in rats reported that 
treadmill exercise suppressed the expression of neuropeptide Y in the hypothalamus 
118 
(Shin et ai, 2003). Shin et al (2003) also suggested that exercise-intensity is an 
important factor in modulating hypothalamic NPY expression with low-intensity 
exercise having a more potent suppressive effect on NPY expression than high-
intensity exercise. These findings indicate that exercise-induced appetite suppression 
could be mediated through the effects of exercise on hypothalamic neuropeptides. 
Future studies should investigate the effects of different modes of exercise on 
appetite regulation by leptin. It is unclear from the present results whether coupling 
between leptin and appetite can also be mediated by higher-intensity exercise. 
The results of Studies 1 and 2 indicate possible similarities and differences in the 
acute appetite control in lean and obese individuals. The drive to eat and the 
reciprocal feelings of satiety and fullness are similar in lean and obese women after a 
short bout of moderate exercise or eating. However, differences may occur in the 
biological regulation of appetite. High serum leptin concentrations may regulate 
short-term appetite in obese individuals but exercise is possibly required to facilitate 
this action of leptin. Additional studies are required to investigate if these differences 
are related to distinct physiologic responses to appetite in obese and lean individuals. 
7.2.2 Conclusions from Study 3 
Adrenaline is unlikely to be the exercise factor responsible for the coupling between 
leptin and satiety since adrenaline infusion stimulated an increase in subsequent 
energy intake in obese women. Noradrenaline is also known to increase leptin uptake 
in rats (Banks, 2001). The plasma threshold concentration, however, for 
cardiovascular and metabolic changes is approximately 10 times higher for 
noradrenaline than for adrenaline (Walsh et ai, 1998). Thus, to mimic physiological 
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effects of exercise using noradrenaline infusion, would pose a potential risk to the 
subjects. For the above reasons, adrenaline alone was chosen for the present study. It 
is known that leptin and noradrenaline (NA) have common hypothalamic targets (e.g. 
NPY) (Wellman, 2000) and their effects are mediated by Ul adrenoceptors. 
Exogenous NA can elicit or reduce eating, depending on the site of infusion 
(paraventricular nucleus) and the relative balance of postsynaptic u2-adrenoceptors 
(stimulate eating) and ul-adrenoceptors (suppress eating). Recently, Ul-
adrenoceptors were found to enhance the transport of leptin through the blood brain 
barrier in mice (Banks, 2001), which extends the anorexigenic action of Ul-
adrenoceptors. Labetalol probably was not a sufficiently strong u-adrenoceptor 
blocker to investigate such effects. Probably a more selective ul_adrenoceptor 
antagonist could aid the investigation of the interaction between leptin and NA in the 
regulation of eating. 
7.2.3 Conclusions from Study 4 
The results from the detraining study are amongst the first reports of an ob protein 
increase with physical inactivity. This is in agreement with Blanc et al (2000) who 
reported an increase in leptin levels after physical inactivity induced by 7 days bed 
rest. Future studies are required to elucidate the effects of physical inactivity on the 
regulation of leptin and on factors related to hexosamine synthesis in normal weight, 
obese and trained individuals. The results in trained individuals (Study 4, Chapter 6) 
suggest that exercise detraining promotes hyperleptinemia and associated metabolic 
risk factors for coronary heart disease (i.e. hyperinsulinemia, insulin resistance). The 
elevated leptin level commonly found in obese people may reflect chronic detraining. 
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Overall summary of the findings 
Fifty years ago, Mayer et al (1956) speculated that the mechanisms controlling 
energy balance are accurate in individuals with higher levels of physical activity, but 
in sedentary individuals there is a threshold of physical activity below which these 
mechanisms become imprecise and result in overweight. The exact mechanisms 
controlling energy balance are still unknown but the findings of the present thesis 
implicate leptin, insulin, insulin resistance and noradrenergic factors in the control of 
appetite. An attempt to synthesise the findings of this thesis, together with existing 
evidence, is made in Figure 7.1, as a progression from the model shown in Figure 
1.1. 
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7.3 New Research Questions that this thesis has identified 
The present thesis identified several new research questions and some future research 
questions are also proposed. 
1. Chapter 3 (Study 1): 'What is the effect of moderate exercise and a mild snack on 
appetite/satiety ratings, subsequent food intake and serum leptin in obese 
women'? 
Moderate physical activity and snack intake suppress the appetite of obese 
women acutely. The associations between circulating leptin and appetite-satiety 
ratings suggest leptin involvement in short-term appetite regulation in response to 
physical activity-induced factors. 
These results suggested a new approach to search the potential therapeutic role of 
recombinant leptin administration in the treatment of obesity: 
'What is the effect of pegylated recombinant human leptin (PEG-OB) on appetite 
control and body weight in conjunction with a moderate physical activity 
programme in obese individuals '? 
2. Chapter 4 (Study 2): 'What is the effect of moderate exercise and a mild snack on 
appetite/satiety ratings, subsequent food intake and serum leptin in lean women? 
Is there a coupling between serum leptin and appetite control following physical 
activity in lean women '? 
Moderate exercise and snack intake suppress the appetite of lean women acutely. 
Serum leptin is not associated with acute appetite regulation after exercise or 
eating in lean women whereas plasma free fatty acids might have a role on 
postprandial satiety in lean women. The acute physiological regulation of 
appetite appears to differ between lean and obese women. 
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Emerging from the results in Chapter 3 (Study 1) and Chapter 4 (Study 2), some 
new research questions are proposed: 
1: 'Is the transport pathway of leptin different between obese and normal weight 
individuals; is the blood brain barrier the predominant controlling site for the 
entry ofleptin into the brain in obese compared to normal weight individuals?' 
3. Chapter 5 (EXP 1): 'What is the effect of moderate exercise performed with a 
combined alP adrenoceptor antagonist on appetite/satiety ratings, subsequent 
food intake and serum leptin in obese women? ' 
Combined a/~ adrenergic blockade with labetalol during moderate exercise did 
not alter appetite control following exercise compared to placebo. It appears that 
a/~ adrenergic stimulation through exercise is not responsible for the increased 
satiety reported previously in obese women. 
Chapter 5 (EXP 2): 'What is the effect of adrenaline infusion on appetite/satiety 
ratings, subsequent food intake and serum leptin in obese women?' 
Elevated plasma adrenaline concentrations increased caloric intake in obese 
women acutely. The ~-adrenergic stimulation does not have a specific role in 
linking physical activity to appetite regulation via enhanced leptin transport. On 
the other hand it may be related with central orexigenic mechanisms. 
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The results in Chapter 5 (EXP 1 and 2) raised some new research questions for 
future studies: 
1: 'What is the effect of noradrenaline infusion on appetite/satiety ratings, 
subsequent food intake and serum leptin in obese women '? 
2: 'What is the effect of moderate exercise performed with a selective a]-
adrenoceptor antagonist on appetite/satiety ratings and food intake in obese 
women?' 
4. Chapter 6 (study 4): 'What is the effect of short-term detraining on serum leptin, 
insulin sensitivity and appetite/satiety measures in endurance-trained men? ' 
A short-term detraining increased serum leptin concentrations, despite the decline 
in insulin sensitivity, but had no effect on fasting and postprandial appetite and 
satiety ratings. Insulin resistance does not appear to block the detraining-induced 
leptin increase. Endurance exercise is needed not only to prevent high levels of 
insulinemia but also leptinemia in trained individuals. 
These results in Chapter 6 raised a new research question for investigation in 
future studies: 
1: 'What is the influence of long-term detraining on serum leptin concentrations, 
insulin sensitivity and energy balance in lean and obese individuals? ' 
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Figure 7.1: Schematic view of the main conclusions from this thesis. 
Moderate exercise induced coupling between circulating leptin and suppressed 
appetite in obese women. It is speculated that the catecholamine-stimulated lipolysis 
following exercise (increased A, NA, FF A) has facilitated the function of leptin by 
enhancing the leptin transport through the BBB (a). Noradrenaline (NA) is more 
likely to be the exercise factor responsible for the coupling between leptin and 
suppressed appetite since adrenaline infusion stimulated an increase in subsequent 
energy intake (b). Detraining factor(s) induced hyperleptinemia, increased,circulating 
insulin concentrations and insulin resistance, which indicate the interrelationship 
between leptin and insulin action in the c~ntrol of energy balance (c). The red 
indicates links strengthened by work in the present thesis. 
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APPETITE QUESTIONNAIRE 
SUbject Number: •................ Study code .........•. 
Name: Date: __ 1 __ 1 __ Visit: -----------
Please answer the following questions by placing a vertical mark through the line for each 
question. 
Regard the end of each line as indicating the most extreme sensation you have ever felt and 
mark how you feel NOW. 
Example 
This is how to mark this line. 
e.g. How happy are you (now)? 
Not at all 
happy 
Time:------
1. How hungry do you feel (now)? 
I am not 
hungry 
at all 
2. How satisfied do you feel (now)? 
lam 
completely 
empty 
3. How full do you feel (now)? 
Not at all 
full 
I 
I 
4. How much do you think you can eat (now)? 
Nothing 
at all 
5. How strong is your desire to eat (now)? 
Not at all 
strong 
IT
; 
I; 
4J 
As happy as 
I have ever 
been 
I have never 
been more 
hungry 
I cannot eat 
another bite 
Totally full 
A lot 
Very strong 
